• +90 312 335 38 18
  • Ankara, TURKEY

YAYINLAR

YAYINLAR

  • 1. Secilmis S, Sinan Dal M, Kizil Cakar M, Merdin A, Ahu Baysal N, Altuntas F. Combination of Venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia: A case series from a single center. J BUON. 2021 Sep-Oct;26(5):2026-2032.
  • 2. Aslan Candır B, Yiğenoğlu TN, Kızıl Çakar M, Dal MS, Altuntaş F. Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities. J Oncol Pharm Pract. 2022 Jan 10:10781552211073885. doi: 10.1177/10781552211073885.
  • 3. Aslan Candır B, Yiğenoğlu TN, Kızıl Çakar M, Dal MS, Altuntaş F. Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease. J Oncol Pharm Pract. 2022 Jan 12:10781552211073881. doi: 10.1177/10781552211073881.
  • 4. Dicle İskender, Seval Yılmaz-Ergani, Munevver Aksoy, Betul Tokgoz, Mujde Can Ibanoglu, Merih Kızıl Çakar, Turhan Caglar, Fevzi Altuntas. High Rate of Obstetric Complications in Patients With Essential Thrombocythemia. Cureus 13(12): e20449. doi:10.7759/cureus.20449.
  • 5. Alparslan Merdin, Mehmet Sinan Dal, Merih Kizil Çakar, Taha Bahsi, Neslihan Düzkale, Jale Yildiz, Mehmet Bakirtaş, Semih Başçi, Tahir Darçin, Derya Şahin, Ayşegül Tetik, Bahar Uncu Ulu, Dicle İskender, Tuğçe Nur Yiğenoğlu, Fevzi Altuntaş. Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center study. Medicine 2021;100 (41): e27458.
  • 6. Pagano L, Salmanton-García J; EPICOVIDEHA working group. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0.
  • 7. Samet Yaman, Semih Başcı, Gökhan Turan Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Single-Dose Rasburicase Might Be Adequate to Overcome Tumor Lysis Syndrome In Hematological Malignancies. Clin Lymphoma Myeloma Leuk. 2021 Aug 28:S2152-2650(21)02012-7. doi: 10.1016/j.clml.2021.08.009.
  • 8. Sinan Dal M, Merdin A, Erkurt MA, Ekinci Ö, Albayrak M, Kabukcu Hacıoglu S, Kaya A, Dogu MH, Hindilerden F, Sarici A, Merter M, Reis Aras M, Akgun Caglıyan G, Kizil Cakar M, Aydogdu I, Kuku I, Korkmaz S, Ulas T, Eser B, Altuntas F. Pralatrexate experience in PTCL: A multicenter retrospective study from Turkey. J BUON. 2021 Jul-Aug;26(4):1536-1539.
  • 9. Mert D, Merdin A, Ceken S, Dal MS, Ertek M, Altuntas F. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin's lymphoma. J Cancer Res Ther. 2021 Jul-Sep;17(4):951-955.
  • 10. Uncu Ulu B, Dal MS, Yönal Hindilerden İ, Akay OM, Mehtap Ö, Büyükkurt N, Hindilerden F, Güneş AK, Yiğenoğlu TN, Başcı S, Kızıl Çakar M, Yanardağ Açık D, Korkmaz S, Ulaş T, Özet G, Ferhanoğlu B, Nalçacı M, Altuntaş F. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. J Chemother. 2021 Sep 13:1-9. doi: 10.1080/1120009X.2021.1976912.
  • 11. Ulu BU, Yiğenoğlu TN, Başcı S, Bakırtaş M, Şahin D, Darçın T, Yaman S, Bozan E, Seçilmiş S, Candır BA, Yıldız J, İskender D, Baysal NA, Çakar MK, Dal MS, Altuntaş F. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma. Leuk Res. 2021 Aug 28;110:106700. doi: 10.1016/j.leukres.2021.106700.
  • 12. Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Derya Şahin, Semih Başcı, Dicle İskender, Yasemin Adaş, Ebru Atasever Akkaş, Tuba Hacıbekiroğlu, Merih Kızıl çakar, Mehmet Sinan DAL, Fevzi Altuntaş. Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation? Cureus 13(11): e19462. doi:10.7759/cureus.19462.
  • 13. Kalpakci Y, Hacibekiroglu T, Darcin T, AkgunCagliyan G, Cakar MK, Hacioglu SK, Ekinci O, Korkmaz S, Albayrak M, Dal MS, Dogan A, Ulas T, Eser B, Altuntas F. Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: A Multicenter Experience in Turkey. Transfus Apher Sci. 2021 Oct;60(5):103244. doi: 10.1016/j.transci.2021.103244.
  • 14. Batgi H, Dal MS, Erkurt MA, Kuku I, Kurtoglu E, Hindilerden IY, Kaya E, Berber I, Ulas T, Altuntas F. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience. Transfus Apher Sci. 2021 Oct;60(5):103242. doi: 10.1016/j.transci.2021.103242.
  • 15. Dal MS, Batgi H, Erkurt MA, Hindilerden IY, Kuku I, Kurtoglu E, Kaya E, Besisik SK, Berber I, Nalcaci M, Ulas T, Altuntas F. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study. Transfus Apher Sci. 2021 Oct;60(5):103243. doi: 10.1016/j.transci.2021.103243.
  • 16. Basturk A, Sayin S, Erkurt MA, Sarici A, Ekinci O, Kum A, Berber I, Korkmaz S, Dogan A, Ulas T, Kuku I, Eser B, Altuntas F. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura. Transfus Apher Sci. 2021 Oct;60(5):103246. doi: 10.1016/j.transci.2021.103246.
  • 17. Başcı S, Yiğenoğlu TN, Yaman S, Bozan E, Ulu BU, Bakırtaş M, Kılınç A, Özcan N, Bahsi T, Dal MS, Çakar MK, Altuntaş F. Does myeloma genetic have an effect on stem cell mobilization? Transfus Apher Sci. 2021 Aug 17:103249. doi: 10.1016/j.transci.2021.103249.
  • 18. Yiğenoğlu TN, Başcı S, Şahin D, Ulaş T, Dal MS, Korkmaz S, Hacıbekiroğlu T, Namdaroğlu S, Erkurt MA, Turgut B, Altuntaş F. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci. 2021 Aug 17:103237. doi: 10.1016/j.transci.2021.103237.
  • 19. Aydin K, Korkmaz S, Erkurt MA, Sarici A, Ekinci O, Baysal NA, Berber I, Dogan A, Dal MS, Giden AO, Ulas T, Kuku I, Ozatli D, Eser B, Altuntas F. Apheresis in patients with sepsis: A multicenter retrospective study. Transfus Apher Sci. 2021 Oct;60(5):103239. doi: 10.1016/j.transci.2021.103239.
  • 20. Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122.
  • 21. Akay OM, Ozbalak M, Pehlivan M, Yildiz B, Uzay A, Yigenoglu TN, Elverdi T, Kaynar L, Ayyildiz O, Yonal Hindilerden I, Goksoy HS, Izmir Guner S, Gunes AK, Sonmez M, Kurt Yuksel M, Civriz Bozdag S, Ozkurt ZN, Toptas T, Dogu MH, Salim O, Saydam G, Yavasoglu I, Ayli M, Ozet G, Albayrak M, Birtas Atesoglu E, Toprak SK, Yildirim R, Mehtap O, Kalayoglu Besisik S, Nalcaci M, Altuntas F, Ferhanoglu B. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study. Hematol Oncol. 2021 Jun 25. doi: 10.1002/hon.2897.
  • 22. Jale Yıldız, Mehmet Sinan Dal, Merih Kızıl Çakar, Tuğçe Nur Yiğenoğlu, Alparslan Merdin, Dicle İskender, Nuran Ahu Baysal, Hikmetullah Batgi, Derya Şahin, Mehmet Bakırtaş, Tahir Darçın, Semih Başçı, Bahar Uncu Ulu, Fevzi Altuntaş. Return to Work of Lymphoma Survivors After Autologous Stem Cell Transplantation: A Single-Center Cross-Sectional Study. Iranian Red Crescent Medical Journal,23(7) . https://doi.org/10.32592/ircmj.2021.23.7.644.
  • 23. Akpinar, S., Dogu, M. H., Celik, S., Ekinci, O., Hindilerden, I. Y., Dal, M. S., ... & Altuntas, F. (2021). THE REAL WORLD EXPERIENCE WITH SINGLE AGENT IBRUTINIB IN RELAPSED/REFRACTORY CLL. Clinical Lymphoma Myeloma and Leukemia. 2021. https://doi.org/10.1016/j.clml.2021.09.010.
  • 24. Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med. 2021 Jun 10. doi: 10.1007/s11739-021-02784-y.
  • 25. Yildiz J, Ulu BU, Yiğenoğlu TN, Başçı S, Darçın T, Bakırtaş M, Şahin D, Batgi H, Merdin A, Baysal NA, İskender D, Çakar MK, Dal MS, Altuntaş F. Is classical Hodgkin lymphoma a different disease in the elderly? A single-center retrospective cohort study. Eur Rev Med Pharmacol Sci. 2021 May;25(10):3655-3660. doi: 10.26355/eurrev_202105_25931.
  • 26. Goren Sahin D, Akay OM, Keklik M, Okan V, Karakus A, Demir C, Erkurt MA, Ilkkilic K, Yildirim R, Akgun Cagliyan G, Aksu S, Dogu MH, Dal MS, Karakus V, Gemici AI, Terzi H, Kelkitli E, Sivgin S, Unal A, Yilmaz M, Ayyildiz O, Korkmaz S, Eser B, Altuntas F. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience. Ann Hematol. 2021 May 14. doi: 10.1007/s00277-021-04554-4.
  • 27. Batgi H, Başçı S, Bakırtaş M, Ulu BU, Yiğenoğlu TN, Yildiz J, İskender D, Özcan N, Dal MS, Çakar MK, Altuntaş F. Effect of the Amount of Autologous Hematopoietic Stem Cells on Survival and Engraftment in Multiple Myeloma. Iranian Red Crescent Medical Journal, 23(5). Retrieved from https://ircmj.org/index. php/ IRCMJ/ article/ view/613.
  • 28. Uncu Ulu B, Yiğenoğlu TN, Hacıbekiroğlu T, Sağlam DA, Kılınç A, İskender G, Çakar MK, Dal MS, Altuntaş F. Recovery of Symmetrical Peripheral Gangrene of Limbs in a Patient After Performing Hemoadsorption in Septic Shock. J Clin Apher. 2021 Mar 23. doi: 10.1002/jca.21893.
  • 29. Başcı S, Yiğenoğlu TN, Bakırtaş M, Uncu Ulu B, Yaman S, Dal MS, Kızıl Çakar M, Altuntaş F. The effect of bulky mass on prognosis in diffuse large-B-cell lymphoma: still poor? Leuk Res. 2021 Mar; 102:106521. doi: 10.1016/j.leukres.2021.106521.
  • 30. Başcı S, Bakırtaş M, Yiğenoğlu TN, Uncu Ulu B, Batgi H, Yıldız J, Dal MS, Kızıl Çakar M, Altuntaş F. The Outcome of Diffuse Large B Cell Lymphoma Patients in Adolescent and Young Adult Age Group. J Adolesc Young Adult Oncol. 2020 Nov 25. doi: 10.1089/jayao.2020.0145.
  • 31. Batgi H, Başci S, Dal MS, Kizil Çakar M, Uncu Ulu B, Yiğenoğlu TN, Özcan N, Kilinç A, Merdin A, Yildiz J, Bakirtaş M, Şahin D, Darçin T, İskender D, Baysal NA, Altuntaş F. Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience. Turk J Med Sci. 2020 Nov 25. doi: 10.3906/sag-2008-114.
  • 32. Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Semih Başcı, Mehmet Bakırtaş, Derya Şahin, Tahir Darçın, Jale Yıldız, Alparslan Merdin, Nuran Ahu Baysal, Dicle İskender, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Autologous Stem Cell Transplantation in Multiple Myeloma Patients Over 60 Years Old. Medical Laboratory Technology Journal 2021. DOI: 10.31964/mltj.v0i0.280
  • 33. Dal MS, Ata N, Altuntaş F, Başci S, Yiğenoğlu TN, Korkmaz S, Namdaroğlu S, Baştürk A, Hacibekiroğlu T, Doğu MH, Berber I, Dal K, Erkurt MA, Turgut B, Çağlayan M, Imrat E, Çelik O, Ülgü MM, Birinci Ş. Covid-19 Clinical Course and Blood Groups: Turkish Population-Based Study. Turk J Med Sci. 2021 May 7. doi: 10.3906/sag-2101-321.
  • 34. Semih Başcı, Mehmet Bakırtaş, Bahar Uncu Ulu, Tuğçe Nur Yigenoğlu, Samet Yaman, Hikmetullah Batgi, Ali Kılınç, Nurgül Özcan, Derya Sahin, Jale Yildiz, Dicle Iskender, Nuran Ahu Baysal, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Old is bad? The effect of age on perıpheral stem cell mobilizatıon and transplantation outcomes. Transfus Apher Sci. 2020. DOI:https://doi.org/10.1016/ j.transci.2020. 103007.
  • 35. Jale Yildiz, Mehmet Sinan Dal,Tugçe Nur Yigenoglu, Hikmetullah Batgi, Bahar Uncu Ulu, Tahir Darçin, Mehmet Bakirtas, Derya Sahin, Alparslan Merdin, Sema Seçilmis, Semih Basçi, Nuran Ahu Baysal, Dicle Iskender, Merih Kizil Çakar, Fevzi Altuntas. Return to Work in Lymphoma Survivors After Autologous Stem Cell Transplantation: A Single Center Cross-Sectional Study. JNMA 2020.
  • 36. Mert D, Merdin A, Ceken S, Dal MS, Ertek M, Altuntas F. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin's lymphoma. J Can Res Ther 2020. DOI: 10.4103/jcrt.JCRT_465_19.
  • 37. Fevzi Altuntaş, Tuğçe Nur Yigenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroglu, Burhan Turgut, Mehmet Ali Erkut. Mesenchymal Stem Cell Therapy in Patients with COVID-19. Transfus Apher Sci. 2021.
  • 38. Semih Başcı, Naim Ata, Fevzi Altuntaş, Tuğçe Nur Yigenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroglu, Abdulkadir Baştürk, Tuba Hacıbekiroglu, Mehmet Hilmi Doğu, İlhami Berber, Kürşad Dal, Mehmet Ali Erkurt, Burhan Turgut, Murat Caglayan, Mustafa Okan Ayvalı, Osman Çelik, Mustafa Mahir Ulgu, Şuayip Birinci. On Behalf of Turkish Ministry of Health, Hematology Scientific Working Group. Patients With Hematological Malignancies Are More Vulnerable to COVID-19 Compared to Patients With Solid Tumors. Annals of Oncology 2020.
  • 39. Fevzi Altuntaş, Naim Ata, Tugce Nur Yigenoglu, Semih Başcı, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroglu, Abdulkadir Baştürk, Tuba Hacıbekiroglu, Mehmet Hilmi Doğu, İlhami Berber, Kürşat Dal, Mehmet Ali Erkurt, Burhan Turgut, Mahir İlgü, Osman Çelik, Ersan İmrat, Şuayip Birinci. On Behalf of Turkish Ministry of Health, Hematology Scientific Working Group. COVID-19 in Hematopoietic Cell Transplant Recipients. Bone Marrow Transplant. 2020 Oct 28. doi: 10.1038/s41409-020-01084-x.
  • 40. Altuntaş F, Ata N, Yiğenoğlu TN, Başcı S, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Kınık K, Haznedaroglu I, FM Yılmaz, Kılıç I, Demircioğlu S, Yosunkaya A, Erkurt MA, Turgut B, Çağlayan M, Çelik O. Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2020 Sep 19:102955. doi: 10.1016/j.transci.2020.102955.
  • 41. Ceken S, Gedik H, Iskender G, Demirelli M, Mert D, Yapar Toros G, Yigenoglu TN, Altuntas F, Oksuzoglu B, Ertek M. Evaluation of Risk Factors fr Mortality in Febrile Neutropenia. J Infect Dev Ctries. 2020 Aug 31;14(8):886-892. doi: 10.3855/jidc.12520.
  • 42. Yildiz F, Durnali A, Eraslan E, Ilhan A, Tufan G, Aslan F, Arslan UY, Alkis N, Demirci U, Altuntas F, Oksuzoglu B. Outcomes of Autologous Stem Cell Transplantation (ASCT) in Relapsed/Refractory Germ Cell Tumors: Single Center Experience from Turkey. Urol J. 2020 Aug 25. doi: 10.22037/uj.v16i7.6004.
  • 43. Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Ayvalı MO, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Aug 27:1078155220953198. doi: 10.1177/1078155220953198.
  • 44. Mert D, Merdin A, Çakar MK, Dal MS, Altuntaş F. Evaluation of HBV, HCV, and HIV seroprevalence in patients with plasma cell disorders. Medicine (Baltimore). 2020 Aug 21;99(34):e21799. doi: 10.1097/MD.0000000000021799.
  • 45. Yigenoglu TN, Ata N, Altuntas F, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Imrat E, Birinci S. The outcome of COVID-19 in patients with hematological malignancy. J Med Virol. 2020 Aug 10:10.1002/jmv.26404. doi: 10.1002/jmv.26404.
  • 46. Yiğenoğlu TN, Hacıbekiroğlu T, Berber İ, Dal MS, Baştürk A, Namdaroğlu S, Korkmaz S, Ulas T, Dal T, Erkurt MA, Turgut B, Altuntaş F. Convalescent Plasma Therapy in Patients with COVID-19. J Clin Apher. 2020 Aug;35(4):367-373. doi: 10.1002/jca.21806.
  • 47. Yiğenoğlu TN, Ulas T, Dal MS, Korkmaz S, Erkurt MA, Altuntaş F. Extracorporeal Blood Purification Treatment Options for COVID-19: The Role of Immunoadsorption. Transfus Apher Sci. 2020 Aug;59(4):102855. doi: 10.1016/j.transci.2020.102855.
  • 48. Nur Soyer, Mehmet Gunduz, Emre Tekgunduz, Burak Deveci, Hakan Ozdogu, Handan Haydaroglu Sahin, Esra Ermis Turak, Mufide Okay, Irfan Kuku, Ipek Yonal Hindilerden, Pervin Topcuoglu, Fevzi Altuntas, Ihsan Karadogan, Mustafa Pehlivan, Ali Unal, Hakan Goker, Mehmet Ali Erkurt, Sevgi Kalayoglu Besısık, Filiz Vural. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of Turkish Hematology Research and Education Group (ThREG). Transfus Apher Sci. 2020 Aug;59(4):102827. doi: 10.1016/j.transci.2020.102827.
  • 49. Bekoz H, Ozbalak M, Karadurmus N, Paydas S, Turker A, Toptas T, Tuglular TF, Altuntas F, Cakar MK, Sonmez M, Gulbas Z, Demir N, Kaynar L, Yildirim R, Karadogan I, Arat M, Kapucu I, Aslan NA, Ozkocaman V, Turgut M, Yuksel MK, Ozcan M, Hacioglu SK, Barista I, Demirkaya M, Saydam G, Toprak SK, Yilmaz M, Demirkol O, Ferhanoglu B. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. Ann Hematol. 2020 Jun 7. doi: 10.1007/s00277-020-04077-4.
  • 50. Alparslan Merdin, Mehmet Sinan Dal, Merih Kizil Çakar, Jale Yildiz, Bahar Uncu Ulu, Hikmetullah Batgi, Aysegül Tetik, Sema Seçilmis, Tahir Darçin, Derya Sahin, Mehmet Bakirtas, Semih Basçi, Tugçe Nur Yigenoglu, Nuran Ahu Baysal, Dicle Iskender, Fevzi Altuntas. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations. Medicine 99 (14): e19627.
  • 51. Batgi H, Merdin A, Sinan Dal M, Kızıl Çakar M, Yıldız J, Başçı S, Uncu Ulu B, Yiğenoğlu TN, Darçın T, Şahin D, Bakırtaş M, Tetik A, İskender D, Altuntaş F. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience. J Oncol Pharm Pract. 2020 Feb 25:1078155220905654. doi: 10.1177/1078155220905654.
  • 52. Büyükaşık Y, Ali R, Turgut M, Saydam G, Yavuz S, Ünal A, Ar MC, Ayyıldız O, Altuntaş F, Okay M, Çiftçiler R, Meletli Ö, Soyer N, Mastanzade M, Güven Z, Soysal T, Karakuş A, Yiğenoğlu TN, Uçar B, Gökçen E, Tuğlular T. Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythaemia Vera: a Multicentre Chart Review Study. Turk J Haematol. 2020 Feb 20. doi: 10.4274/tjh.galenos.2020.2019.0431.
  • 53. Mert D, Ceken S, Iskender G, Iskender D, Merdin A, Duygu F, Ertek M, Altuntas F. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies. J Infect Dev Ctries. 2019 Aug 31;13(8):727-735. doi: 10.3855/jidc.11457.
  • 54. Batgi H, Sinan Dal M, Merdin A, Kızıl Çakar M, Yiğenoğlu TN, Altuntaş F. A multiple myeloma patient who developed ischemic colitis during lenalidomide treatment: A rare case report. J Oncol Pharm Pract. 2020 Feb 6:1078155219900910. doi: 10.1177/1078155219900910.
  • 55. Tuğçe Nur Yiğenoğlu, Semih Başcı, Bahar Uncu Ulu, Mehmet Bakırtaş, Ali Kılınç, Tahir Darçın, Jale Yıldız, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş. Inferior prognosis in poor mobilizing myeloma patients. Transfus Apher Sci. 2020 Jun;59(3):102722. doi: 10.1016/j.transci.2020.102722.
  • 56. Tuğçe Nur Yiğenoğlu, Semih Başcı, Mehmet Bakırtaş, Bahar Uncu Ulu, Ali Kılınç, Derya Şahin, Tahir Darçın, Jale Yıldız, Alparslan Merdin, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş. The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors. Transfus Apher Sci. 2020 Jun;59(3):102726. doi: 10.1016/j.transci.2020.102726.
  • 57. Merdin A, Çakar MK, Dal MS, Mert D, Yıldız J, Başçı S, Bakırtaş M, Darçın T, Şahin D, Ulu BU, Yiğenoğlu TN, Batgi H, Tetik A, İskender D, Altuntaş F. Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor. J Oncol Pharm Pract. 2020 Jun;26(4):929-932. doi: 10.1177/1078155219891663.
  • 58. Mert D, Merdin A, Ceken S, Sinan Dal M, Ertek M, Altuntas F. Development of pneumonitis after rituximab treatment in a patient with lymphoma.J Oncol Pharm Pract. 2020 Jun;26(4):1009-1010. doi: 10.1177/1078155219879496.
  • 59. Okay M, Aslan T, Ozdemir E, Uner A, Saglam A, Gungor E, Uysal A, Alayvaz Aslan N, Yildizhan E, Agit A, Dal MS, Korkmaz S, Namdaroglu S, Sivgin S, Akgun Cagliyan G, Demircioglu S, Barista I, Ozhamam E, Vural F, Eser B, Ozet G, Yildirim R, Dogu MH, Berber I, Erkurt MA, Malkan UY, Altuntas F, Buyukasik Y. Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study. Turk J Haematol. 2020 May 6;37(2):84-90. doi: 10.4274/tjh.galenos.2019.2019.0177.
  • 60. Tuğçe Nur Yigenoğlu, Mehmet Bakırtaş, Semih Başcı, Bahar Uncu Ulu, Derya Şahin, Ali Kılınç, Fatma Nurbüke Şarkışla, Dicle İskender, Nurgül Özcan, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş. Blood group A is a negative risk factor for peripheric blood stem cell mobilization in allogeneic donors. Medical Science and Discovery 2020;7(6):505-508. https://doi.org/ 10.36472/msd.v7i6.382.
  • 61. Olga Meltem Akay; Murat Ozbalak; Birol Yıldız; Mustafa Pehlivan; Tuğçe Nur Yiğenoğlu; Ant Uzay; İpek Yönal Hindilerden; Hasan Sami Göksoy; Şebnem İzmir Güner; Ahmet Kürşad Güneş; Mehmet Sonmez; Meltem Kurt Yüksel; Orhan Ayyıldız; Leylagül Kaynar; Mehmet Hilmi Doğu; Tuğrul Elverdi; Ozan Salim; Güray Saydam; İrfan Yavaşoğlu; Meltem Aylı; Gülsüm Özet; Tayfur Toptaş; Murat Albayrak; Elif Birtaş Ateşoğlu; Zübeyde Nur Özkurt; Selami K Toprak; Rahşan Yıldırım; Meliha Nalçacı; Fevzi Altuntaş; Burhan Ferhanoğlu. Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin’s Lymphoma: Multi-Center Real-Life Experience. International Journal of Clinical Oncology 2020.
  • 62. Başcı S, Yiğenoğlu T.N., Bakırtaş M., Ulu B. U., Şahin D., Darçın T., Yıldız J., İskender D., Baysal N. A., Dal M. S., Çakar M. K., & Altuntaş F. (2020). Bone marrow plasma cell ratio, is it must to evaluate before autologous stem cell transplantation in multiple myeloma? Medical Science and Discovery, 7(4), 470-474. https://doi.org/10.36472/msd.v7i4.372.
  • 63. Semih Başcı, Tuğçe Nur Yiğenoğlu, Bahar Uncu Ulu, Mehmet Bakırtaş, Derya Şahin, Tahir Darçın, Jale Yıldız, Alparslan Merdin, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş. Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents. Medical Laboratory Technology Journal 2020. DOI: 10.31964/mltj.v0i0.281.
  • 64. Bahsi T, Yigenoglu TN, Erdem HB, Çakar MK, Dal MS, Altuntas F. Evaluation of Clinical Outcome and Mixed Chimerism Follow-up after Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies. Gazi Medical Journal 31:52-55. DOI: 10.12996/gmj.2020.13.
  • 65. Mehmet Bakırtaş, Tuğçe Nur Yiğenoğlu, Semih Başcı, Bahar Uncu Ulu, Nurgül Özcan, Dicle İskender, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Second Allogeneic Stem Cell Transplantation in Acute Leukemia Patients: Single Center Experience. Jurnal Teknologi Laboratorium, 2020. doi.org/10.29238/teknolabjournal.v9i1.208.
  • 66. Mehmet Bakirtas, Tugce Nur Yigenoglu, Semih Basci, Bahar Uncu Ulu, Nurgul Ozcan, Merih Kizil Cakar, Mehmet Sinan Dal, Fevzi Altuntas. Outcome of allogeneic stem cell transplantation with active disease in acute myeloid leukemia. Sanamed 2020; 15(1): 15–19. DOI: 10.24125/sanamed.v15i1.397.
  • 67. Tuğçe Nur Yiğenoğlu, Derya Şahin, Semih Başcı, Mehmet Bakırtaş, Tahir Darçın, Jale Yıldız, Bahar Uncu Ulu, Dicle İskender, Nuran Ahu Baysal, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş. Evaluation of seasonal changes in the diagnosis of acute leukemia in Turkey. Medical Science and Discovery 2020; 7(5):501-4. Doi: 10.36472/msd.v7i5.38.
  • 68. Gulsen Iskender, Sabahat Ceken, Mustafa Cihat Ogan, Omur Kayıkcı, Habıp Gedik, Emre Tekgunduz, Fevzi Altuntas, Mustafa Ertek. Hepatitis B virus reactivation in patients with hematological malignancies under lamivudine prophylaxis. Acta Medica Mediterranea 2019;5:2417. Doi: 10.19193/0393-6384_2019_5_377.
  • 69. Merdin A, İskender D, Ulu BU, Doğan M, Çakar MK, Dal MS, Altuntaş F. Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment. Medicine (Baltimore). 2019 Jul;98(30):e16482. doi: 10.1097/MD.0000000000016482.
  • 70. Duygu Mert, Sabahat Çeken, Gulsen Iskender, Dicle Iskender, Merdin Alparslan, Fazilet Duygu, Mustafa Ertek, Fevzi Altuntas. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies. J Infect Dev Ctries 2019;13 (8):727-735. doi: 10.3855/jidc.11457.
  • 71. Ciftciler R, Gökmen Sevindik Ö, Tekgündüz AİE, Erkurt MA, Vural F, Turgut B, Kaynar L, Payzın B, Doğu MH, Karakuş V, Altuntaş F, Buyukasık Y, Demirkan F. Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study. Turk J Haematol. 2019 May 27. doi: 10.4274/tjh.galenos.2019.2019.0008.
  • 72. Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial. Lancet Oncol. 2019 May 13. pii: S1470-2045(19)30152-4. doi: 10.1016/S1470-2045(19)30152-4.
  • 73. Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, Dogu MH, Gulturk E, Ulas T, Payzin B, Kuku I, Cagirgan S, Altuntas F. The Turkish experience with therapeutic plasma exchange: A national survey. Transfus Apher Sci. 2019 Apr 23. pii: S1473-0502(19)30064-3. doi: 10.1016/j.transci.2019.04.015.
  • 74. Namdaroğlu S, İskender D, Dal MS, Çakar MK, Tekgunduz E, Altuntaş F. Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease. Hong Kong J Dermatol Venereol 2019; 27:12-18
  • 75. Kaya AH, Tekgündüz E, Akpınar S, Bozdağ G, Yiğenoğlu TN, Merdin A, Namdaroğlu S, Kayıkçı Ö, Altuntaş F. Assessment of Ovarian Reserve with anti-Mullerian Hormone in Women Following Allogeneic Hematopoietic Cell Transplantation. Clinical and Experimental Obstetrics Gynecology, 2019:46(1):127-130.
  • 76. Çalışkan EG, Şen K, Merdin A, Dal S, Altuntas F. Illness perception of the patients with hematological cancers: A single center study. International Journal of Pharma and Bio Sciences May 2019:10(2). DOI: 10.22376/ijpbs.2019.10.2.b204-210.
  • 77. Çakar MK, Tekgündüz E, Dal MS, Merdin A, Başçı S, İskender D, Uğur B, Bekdemir F, Yıldız J, Ulu BU, Bakırtaş M, Yiğenoğlu TN, Batgi H, Kaya AH, İskender D, Altuntaş F. The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma. J Oncol Pharm Pract. 2019 Apr 2:1078155219841110. doi: 10.1177/1078155219841110.
  • 78. Namdaroglu S, Kaya AH, Batgi H, Kayikci O, Dal MS, Iskender D, Kizil Cakar M, Tekgunduz E, Altuntas F. Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Sci Rep. 2019 Feb 14;9(1):2046.
  • 79. Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. N Engl J Med. 2018 Feb 8;378(6):518-528.
  • 80. Kaya AH, Namdaroğlu S, Kayıkcı Ö, Merdin A, Batgi H, İskender D, Dal MS, Kızıl Çakar M, Tekgunduz E, Altuntas F. Impact of Guideline-Driven Approach in Follow-Up of Long-Term Complications After Allogeneic Hematopoietic Cell Transplant: Single Center Experience. Exp Clin Transplant. 2018 Sep 25. doi: 10.6002/ect.2018.0007.
  • 81. Altuntas F. Message from the incoming WAA president. Transfus Apher Sci. 2018 May 18. pii: S1473-0502(18)30170-8. doi: 10.1016/j.transci.2018.05.002.
  • 82. Sabahat Çeken, Gulsen Iskender, Habip Gedik, Fazilet Duygu, Duygu Mert, Ali Hakan Kaya, Fevzi Altuntas, Mustafa Ertek. Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients. J Infect Dev Ctries 12 (4):265-272. doi: 10.3855/jidc.9720.
  • 83. Tekgündüz E, Yılmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study. Transfus Apher Sci. 2018 Feb 20. pii: S1473-0502(18)30046-6. doi: 10.1016/j.transci.2018.02.012.
  • 84. Dogu MH, Batgi H, Erkurt MA, Hacioglu S, Tekgunduz E, Kaya E, Iskender D, Eren R, Kuku I, Altuntas F. Stem cell mobilization kinetics in elderly patients with multiple myeloma. Transfus Apher Sci. 2018 Feb 1. pii: S1473-0502(18)30018-1. doi: 10.1016/j.transci.2018.01.010.
  • 85. Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678.
  • 86. Kaya AH, Tekgündüz E, Ilkkiliç K, Dal MS, Merdin A, Karakus A, Hacioglu SK, Bekdemir F, Çakar MK, Dogu MH, Ayyildiz MO, Korkmaz S, Altuntaş F. Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy. J Chemother. 2018 Feb;30(1):44-48.
  • 87. Sevindik OG, Korkmaz S, Altuntas F. Current status of art mobilization in Myeloma. Transfus Apher Sci. 2017 Dec;56(6):850-853.
  • 88. Fevzi Altuntaş, Serdal Korkmaz. Hematopoietic progenitor cell mobilization. Transfus Apher Sci. 2017 Dec;56(6):787.
  • 89. Ömür Kayıkçı, EmreTekgündüz, Ali Hakan Kaya, Hakan Göker, Alma Aslan, Dicle İskender, Sinem Namdaroglu, Aysegul Tetik, Şerife Koçubaba, Fevzi Altuntaş. Biosimilar filgrastim (leucostim®️) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen®️) and lenograstim (granocyte®️): A retrospective multicenter study. Transfus Apher Sci. 2017 Dec;56(6):832-835.
  • 90. Namdaroglu S, Korkmaz S, Altuntas F. Management of mobilization failure in 2017. Transfus Apher Sci. 2017 Dec;56(6):836-844.
  • 91. Mehmet Hilmi Dogu, Seçkin Çagirgan, Serkan Ocakci, Ali Hakan Kaya, Kadir Ilkkilic, Neslihan Mandaci Sanli, Selda Kahraman, Rafet Eren, Emre Tekgunduz, Sibel Hacioglu, Leylagul Kaynar, Mehmet Ali Erkurt, Fevzi Altuntas. Autologous Stem Cell Transplantation and Stem Cell Mobilization Kinetics in Elderly Patients with B Cell Non-Hodgkin Lymphoma. Transfus Apher Sci. 2017 Dec;56(6):814-818
  • 92. Serdal Korkmaz, Fevzi Altuntas. What is the role of biosimilar G-CSF agents in hematopoietic stem cell mobilization at present? Transfus Apher Sci. 2017 Dec;56(6):795-799.
  • 93. Emre Tekgündüz, Mutlu Arat, Hakan Göker, Hakan Özdoğu, Leylagül Kaynar, Seçkin Çağırgan, Mehmet Ali Erkurt, Filiz Vural, İlhami Kiki, Fevzi Altuntaş, Fatih Demirkan, on behalf of Turkish Society of Apheresis (TSA). Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: a position-statement from the Turkish society of apheresıs (TSA). Transfus Apher Sci. 2017 Dec;56(6):845-849.
  • 94. Emre Tekgündüz, Fatih Demirkan, Filiz Vural, Hakan Göker, Hakan Özdoğu, İlhami Kiki, İsmet Aydoğdu, Leylagül Kaynar, Mehmet Ali Erkurt, Seçkin Çağırgan, Sevgi Beşışık, Simten Dağdaş, Ebru Koca, Gürhan Kadıköylü, Eren Gündüz, Mehmet Yılmaz, Hüseyin Beköz, Ali Uğur Ural, Fevzi Altuntaş. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG). Transfus Apher Sci. 2017 Dec;56(6):804-808.
  • 95. Kaya AH, Tekgunduz E, Akpinar S, Batgi H, Bekdemir F, Kayikci O, Namdaroglu S, Ulu BU, Dal MS, Cakar MK, Korkmaz S, Altuntas F. Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting? Transplant Proc. 2017 Oct;49(8):1911-1915.
  • 96. Gemici A, Aydogdu I, Terzi H, Sencan M, Aslan A, Kaya AH, Dal MS, Akay MO, Dogu MH, Ayyildiz O, Sahin F, Cagliyan GA, Yilmaz M, Gokgoz Z, Bilen Y, Demir C, Sevindik OG, Korkmaz S, Eser B, Altuntas F. Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience. Hematol Oncol. 2017 Jul 14. doi: 10.1002/hon.2460.
  • 97. Duygu Mert, Hikmetullah Batgi, Alparslan Merdin, Sabahat Çeken, Mehmet Sinan Dal, Emre Tekgündüz, Fevzi Altuntaş, Mustafa Ertek. BK virus-associated hemorrhagıc cystitis in patients wıth allogeneıc hematopoıetıc cell transplantation: report of three cases. Hematology Reports 2017;9(2):76-77. DOI: https://doi.org/10.4081/hr.2017.7205.
  • 98. Mert D, Iskender G, Duygu F, Merdin A, Dal Mehmet S, Dogan M, Tekgündüz E, Ertek M, Altuntaş F. Invasive Aspergillosis with Disseminated Skin Involvement in a Patient with Acute Myeloid Leukemia: A Rare Case. Hematol Rep. 2017 Jun 1;9(2):6997.
  • 99. Merdin A, Yıldız J, Dal MS, Kızıl Çakar M, Kaya AH, Tekgündüz E, Altuntaş F. Coexistence of chronic lymphocytic leukemia and multiple myeloma, do the roots of these entities originate from the same place? Clin Case Rep. 2017 Apr 12;5(6):1032-1033.
  • 100. Merdin A, Yıldız J, Dal Mehmet S, Çakar MK, Batgi H, Tekgündüz E, Onursever A, Altuntaş F.A 80-Year-Old Woman with B-Cell Prolymphocytic Leukemia.Hematol Rep. 2017 Mar 22;9(1):6995.
  • 101. Ali Hakan Kaya, Emre Tekgündüz, Fazilet Duygu, Dicle İskender, Filiz Bekdemir, Hikmetullah Batgi, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Fevzi Altuntas. Risk adapted management of febrile neutrepenia in hematopoietic stem cell transplantation setting: Is it time for early cessation of empirical antibiotherapy? Balkan Med J 2017;34:132-9.
  • 102. Mehmet Sinan Dal, Emre Tekgündüz, Merih Kızıl Çakar, Ali Hakan Kaya, Sinem Namdaroğu, Hikmetullah Batgi, Filiz Bekdemir, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Ali Kılınç, Dicle İskender, Bilge Uğur, Şerife Koçubaba, Gülşen İskender, Fevzi Altuntas. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?. Transfus Apher Sci. 2016 Aug;55(1):125-8.
  • 103. Emre Tekgündüz, İsmail Sarı, Arif Kapuağası, Doğan Ünal, İrfan Şencan, Fevzi Altuntaş. Apheresis Training In Turkey. Transfus Apher Sci. 2016 Apr;54(2):173-5.
  • 104. Mehmet Sinan Dal, Abdullah Karakuş, Merih Kızıl Çakar, Bahar Uncu Ulu, Elif Hattapoğlu, Mehmet Önder Ekmen, Turgay Ulaş, Emre Tekgündüz, Fevzi Altuntaş, Orhan Ayyıldız. Does the eltrompobag treatment safe or effective for refractory chronic immune thrombocytopenia patients? Int J Clin Exp Med 2016;9(9):18707-18711.
  • 105. Tekgündüz, Emre, Ali Hakan Kaya, and Fevzi Altuntaş. "What Is the Optimal Consolidation Strategy for Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients in First Complete Remission if You Are Not Able to Look for Minimal Residual Disease?."International Journal of Hematology Research 2.2 (2016): 130-135.
  • 106. Fatih Kurnaz, Cem Sahin, Leylagul Kaynar, Cigdem Pala, Serdar Sivgin, Fevzi Altuntas, Bulent Eser, Mustafa Cetin, Ali Unal. Factors affecting survival in acute leukemia with donor lymphocyte infusion in the first relapse after allogeneic stem cell transplantation. JBUON 2016; 21(1): 227-234.
  • 107. Namdaroğlu S, Tekgunduz E, Altuntas F. Coexistence of essential thrombocythemia, iron-refractory iron deficiency anemia and renal cell carcinoma. Hematol Rep. Mar 18;8(1):6235. doi: 10.4081/hr.2016.6235.
  • 108. Emre Tekgündüz, Hakan Göker, Leylagül Kaynar, İsmail Sarı, Çiğdem Pala, Mehmet Hilmi Doğu, Erman Öztürk, Burhan Turgut, Serdal Korkmaz, Ayşegül Tetik, Yahya Büyükaşık, Sibel Kabukçu Hacıoğlu, Sinem Civriz Bozdağ, Evren Özdemir, Fevzi Altuntaş. Adult Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience. Clin Lymphoma Myeloma Leuk. 2016 May;16(5):269-74.
  • 109. Altuntas F. Brief Biography: Prof. Dr. Fevzi Altuntaş. Transfus Apher Sci. 2016 Apr;54(2):176. doi: 10.1016/j.transci.2016.04.003.
  • 110. Emre Tekgündüz, İsmail Sarı, Fevzi Altuntaş. Guest editorial. Transfus Apher Sci September 2015. DOI: http://dx.doi.org/10.1016/j.transci.2016.01.005.
  • 111. Emre Tekgündüz, İrfan Şencan, Arif Kapuağası, Doğan Ünal, Murat Öztürk, Hakan Göker, Emine Betül Tavil, Mehmet Ertem, Mustafa Çetin, Mutlu Arat, Teoman Soysal, Osman Karakaşlı, Halil Yılmaz Sur, Akif Yeşilipek, Burhan Ferhanoğlu, Duygu Uçkan, Osman İlhan, Fevzi Altuntas. Hematopoietic Cell Transplantation Activity In Turkey 2014: Ongoing Increase In HCT Rates. Transfus Apher Sci 2016 Feb;54(1):53-9.
  • 112. Hayriye Dilek Yalvaç, Zeynep Kotan, Emre Tekgündüz, Ali Çayköylü, Fevzi Altuntaş. Could psychiatric assessment before hematopoietic stem cell transplantation predict the need for psychiatric consultation during transplantation period? Transfus Apher Sci. 2016 Feb;54(1):85-90.
  • 113. Emre Tekgündüz, Leylagül Kaynar, Hakan Göker, Ali Hakan Kaya, Esra Ermiş Turak, Gürsel Güneş, Ömür Kayıkçı, Mustafa Çetin, Yahya Büyükaşık, Fevzi Altuntaş. Retrospective Analysis Of Adult Patients With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: A Multicenter Experience Of Daily Practice. Transfus Apher Sci 2016 Feb;54(1):41-7.
  • 114. Emre Tekgündüz, Ali Hakan Kaya, Sinem Civriz Bozdağ, Şerife Koçubaba, Ömür Kayıkçı, Sinem Namdaroğlu, Bilge Uğur, Seval Akpınar, Hikmetullah Batgi, Filiz Bekdemir, Fusun Ozdemirkıran, Fevzi Altuntaş. Does Defibrotide Prophylaxis Decrease The Risk Of Acute Graft Versus Host Disease Following Allogeneic Hematopoietic Cell Transplantation? Transfus Apher Sci 2016 Feb;54(1):30-4.
  • 115. Mehmet Ali Erkurt, Ilhami Berber, Emre Tekgunduz, Mehmet Hilmi Dogu, Serdal Kormaz, Cengiz Demır, Mehmet Yılmaz, Olga Meltem Akay, Ciğdem Pala, Yusuf Bılen, Emin Kaya, Ismail Sarı, Mehmet Sencan, Irfan Kuku, Fevzi Altuntas, Sinan Dal, Ismet Aydogdu. Primary Central Nervous System Lymphoma In Daily Practice and The Role Of Autologous Stem Cell Transplantation In Relapsed Disease: A Retrospective Multicenter Study. Transfus Apher Sci. 2016 Feb;54(1):80-4.
  • 116. Mehmet Hilmi Dogu, Ali Hakan Kaya, Ilhami Berber, Ismail Sarı, Emre Tekgunduz, Mehmet Ali Erkurt, Dicle Iskender, Omur Kayıkcı, Irfan Kuku, Emin Kaya, Ali Keskın, Fevzi Altuntas. Does The Preference Of Peripheral Versus Central Venous Access In Peripheral Blood Stem Cell Collection/Yield Change Stem Cell Kinetics In Autologous Stem Cell Transplantation? Transfus Apher Sci. 2016 Feb;54(1):76-9.
  • 117. Khamid Karimov, Emre Tekgündüz, Alonur Saidov, Ömür Kayıkçı, Kodirzhon Boboev, Şerife Koçubaba, Abdurakhmon Kayumov, Ali Kılınç, Gülşen Adıbelli, Abdumannon Isroilov, Tuğçe Nur Türközü, Halil Yılmaz Sur, Nurullah Zengin, Fevzi Altuntaş. First Hematopoietic Cell Transplantation In Uzbekistan: Progress Through Education And Cooperation. Transfus Apher Sci. 2016 Feb;54(1):60-2.
  • 118. Sinem Civriz Bozdag, Emre Tekgunduz, and Fevzi Altuntas. Treatment of acute graft versus host disease with mesancyhmal stem cells: questions and answers. Transfus Apher Sci. 2016 Feb;54(1):71-5.
  • 119. Berber I, Erkurt MA, Keklik M, Dogu MH, Terzi H, Pala C, Sarı HI, Sencan M, Sıvgın S, Hacıoglu S, Altuntas F, Aydogdu, Ilhan O. Clinical characteristics, post-treatment assessment and prognostic factors affecting patient survival of patients at 65 years of age or older with hodgkin lymphoma: A retrospective multicenter study from Turkey. Acta Medica Mediterranea Sep 2015; 31(6):907-914.
  • 120. Onur Esbah, Emre Tekgündüz, Itır Şirinoğlu Demiriz, Sinem Cıvrız Bozdağ, Ali Kaya, Ayşegül Teti, Ömür Kayıkcı, Gamze Durgun, Şerife Kocubaba, Fevzi Altuntaş. Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of Beam and High Dose ICE. Turk J Hematol 2015;32-1-14.doi: 10.4274/tjh.2014.0214.
  • 121. Sinem Civriz Bozdag, Emre Tekgunduz, and Fevzi Altuntas. The Current Status in Hematopoietic Stem Cell Mobilization. J Clin Apher. 2015 Mar 19. doi: 10.1002/jca.21374.
  • 122. Türker K, Albayrak M, Oksüzoğlu B, Balc E, Oğan MC, Iskender G, Altuntaş F. Entecavir as a first-line treatment for hepatitis B virus reactivation following polychemotherapy for chronic lymphocytic leukemia and invasive ductal carcinoma: a report of two cases and review of the literature. Eur J Gastroenterol Hepatol 2015;27 (1):39-45.
  • 123. Punzel M, Korukluoğlu G, Caglayik DY, Menemenlioglu D, Bozdag SC, Tekgündüz E, Altuntaş F, Campos Rde M, Burde B, Günther S, Tappe D, Cadar D, Schmidt-Chanasit J. Dengue virus transmission by blood stem cell donor after travel to sri lanka; Germany, 2013. Emerg Infect Dis. 2014 Aug;20(8):1366-9.
  • 124. Altuntas F, et al. International survey on apheresis. J Clin Apher 2014 (Report of an international survey on apheresis by the ASFA international affairs committee).
  • 125. Demiriz IŞ, Tekgündüz E, Bozdağ SC, Altuntaş F. Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma. Turk J Hematol 2014;31:92-94.
  • 126. Bozdag SC, Namdaroglu S, Kayikci O, Kaygusuz G, Demiriz I, Cinarsoy M, Tekgunduz E, Altuntas F. Diagnosis of large granular lymphocytic leukemia in a patient previously treated for acute myeloblastic leukemia. Hematol Rep. 2013 Dec 23;5(4):e14.
  • 127. Unal A, Altuntaş F. Editorial. Transfus Apher Sci 2013;48 (3):291.
  • 128. Itır Şirinoğlu Demiriz, Emre Tekgündüz, Sinem Civriz Bozdağ, Fevzi Altuntaş. How to be succesful in hematopoietic stem cell mobilization. Bone Marrow Research 2013.
  • 129. Sinem Namdaroğlu, Emre Tekgündüz, Sinem Civriz Bozdağ, Gamze Durgun, Abdurrahman Sarıca, Itır Şirinoğlu Demiriz, Şerife Koçubaba, Gülşen İskender, Ömür Kayıkçı, Fevzi Altuntaş. Microbial contamination of hematopoietic progenitor cell products. Transfus Apher Sci 2013;48 (3): 403-406.
  • 130. Sinem Civriz Bozdağ, Emre Tekgündüz, Gamze Durgun, Abdurrahman Sarıca, Itır Şirinoğlu Demiriz, Şerife Koçubaba, Fevzi Altuntaş. Which regimen is better for stem cell mobilization of lymphoma patients? Transfus Apher Sci. 2013;48 (3): 407-410.
  • 131. Itır Şirinoğlu Demiriz, Sinem Civriz Bozdağ, Emre Tekgündüz, Bilge Uğur, Gamze Durgun, Şerife Koçubaba, Fevzi Altuntaş. Predicting the successful peripheral blood stem cell harvesting. Transfus Apher Sci 2013;48 (3): 411-414.
  • 132. Oztürkmen S, Altuntaş F, Olcay L. Granulocyte transfusion therapy in paediatric patients with severe neutropenic infection. Transfus Apher Sci. 2013 ;48 (3): 381-5.
  • 133. Kaya E, Keklik M, Sencan M, Yilmaz M, Keskin A, Kiki I, Erkurt MA, Sivgin S, Korkmaz S, Okan V, Doğu MH, Unal A, Cetin M, Altuntaş F, Ilhan O.Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis. Transfus Apher Sci. 2013;48 (3):349-52.
  • 134. Korkmaz S, Keklik M, Sivgin S, Yildirim R, Tombak A, Kaya ME, Acik DY, Esen R, Hacioglu SK, Sencan M, Kiki I, Tiftik EN, Kuku I, Okan V, Yilmaz M, Demir C, Sari I, Altuntas F, Unal A, Ilhan O. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study. Transfus Apher Sci. 2013 ;48 (3):353-8.
  • 135. IS. Demiriz, E. Tekgunduz, A. Tetik, Ö. Kayikci, F. Altuntaş. Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: A case report. Transfus Apher Sci, 48(1),109-11, (2013).
  • 136. IS. Demiriz, E. Tekgunduz, F. Altuntaş. What Is the Most Appropriate Source for Hematopoietic Stem Cell Transplantation? Peripheral Stem Cell/Bone Marrow/Cord Blood," Bone Marrow Research 2012;2012:834040. doi: 10.1155/2012/834040. Epub 2012 Sep 27.
  • 137. E. Tekgündüz, F. Altuntaş, S. Şılgın, ZS. Akı, A. Dönmez, P. Topçuoğlu, R. Yıldırım, N.Baysal, E. Ayyıldız, MK. Yüksel, I.Sarı, M. Tombuloğlu, A. Ünal, O. İlhan. Plerixafor use in patients with previous mobilizaton failure: a multicenter experience. Transfus Apher Sci, 47(1),77-80, (2012).
  • 138. F. Altuntaş, A. Unal, O. Ilhan. Turkish Apheresis Activity for 2011. Transfus Apher Sci, 47(1),57-8, (2012).
  • 139. MK. Yüksel, E. Tekgündüz, C. Sönmez, P. Topcuoglu, A. Yurtcu, IS. Demiriz, A. Tetik, Ö. Kayıkçı, M. Cınarsoy, F. Altuntaş. A feasible shortcut for the mobilization outcome: steady state CD34 positive hematopoietic stem cells. Transfus Apher Sci, 47(1), 67-75, (2012).
  • 140. N. Ciledag, K. Arda, BK. Arıbas, E. Tekgunduz, F. Altuntaş. The role of multidetector computed tomography in early diagnosis of invasive pulmonary aspergillosis in patients with febrile neutropenia undergoing hematopoietic stem cell transplantation. Turk J Hematol, 29, 28-33, (2012).
  • 141. ŞH. Arslan, Ü. Üyetürk, E. Tekgündüz, SÇ. Irkkan, MK.Yüksel, IS. Demiriz, F. Altuntaş. Diffuse Large B–Cell Lymphoma Transformed From Primary Breast Mucosa Associated Lymphoid Tissue Lymphoma: A Case Report. Turk J Hematol, 29, 274-277 (2012).
  • 142. Ü. Üyetürk, ŞH. Arslan, MK. Yüksel, F. Altuntaş. Paclitaxel Therapy And Immune Thrombocytopenic Purpura: Coincidence Or Association? Turk J Hematol, 28,151-2, (2011).
  • 143. E. Tekgunduz, MK. Yuksel, C. Erbay, B. Aribas, C. Ozdilekcan, H. Arslan, . Kocubaba, I. Demiriz, A. Tetik, K. Arda, F. Altuntaş. Pandemic 2009 H1N1 influenza in patients with hematopoietic stem cell transplantation and hematologic malignancy: Single Centre Experience. Oncology, 79(5-6), 409-414, (2010).
  • 144. C. Saatci, AO. Caglayan, I. Kocyigit, H. Akalin, LG. Kaynar, F. Altuntas, B. Eser, M. Demir, M. Cetin, Y. Ozkul. Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma? Hematology, 15(1), 39-42 (2010).
  • 145. S. Hacioglu, F. Altuntaş, L. Kaynar, I. Sarı, T. Patıroglu, M. Cetin. Rhabdomyolysis in a Healthy Peripheral Blood Stem Cell Donor Following the Mobilization with Filgrastim. Transfus Med Hemother, 36(2), 135-137, (2009).
  • 146. S. Gokahmetoglu, L. Kaynar, F. Altuntaş, O. Yildiz, M. Cetin, I. Kocyigit. Detection and quantification of cytomegalovirus in bone marrow transplant recipients by real time PCR and pp65 antigenemia. Saudi Med J, 29(11), 1673-75, (2008).
  • 147. F. Altuntaş, K. Matevosyan, J. Burner, S. Yu-Min, R. Sarode. Higher Optical Density of an Antigen Assay Predicts Thrombosis in Patients with Heparin- Induced Thrombocytopenia. Eur J Haematol, 80(5), 429-35, (2008).
  • 148. I. Sarı, F. Altuntaş, S. Hacioglu, I. Kocyigit, A. Sevinc, S. Sacar, K. Deniz, E. Alp, B. Eser, O. Yildiz, L. Kaynar, A. Unal, M. Cetin. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis. Am J Hematol, 83(4), 334-39, (2008).
  • 149. L. Kaynar, F. Altuntaş, I. Aydogdu, B. Turgut, I. Kocyigit, SK. Hacıoglu, S. Ismailogulları, N. Turgut, MA. Erkurt, I. Sarı, M. Oztekin, M. Solmaz, B. Eser, AO. Ersoy, A. Unal, M. Cetin. Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study. Transfus Apher Sci, 38(2),109-115, (2008).
  • 150. I. Sarı, A. Cetin, L. Kaynar, R. Saraymen, SK. Hacioglu, A. Ozturk, I. Kocyigit, F. Altuntaş, B. Eser. Disturbance of the Pro-oxidative/Antioxidative Balance in Allogeneic Peripheral Blood Stem Cell Transplantation. Ann Clin Lab Sci, 38(2), 120-25, (2008).
  • 151. F. Altuntaş, I. Sarı, I. Kocyigit, L. Kaynar, S. Hacioglu, A. Ozturk, M. Oztekin, M. M. Solmaz, B. Eser, M. Cetin, A. Unal. Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators. Transfus Med Hemother, 35, 368-373, (2008).
  • 152. I. Sarı, I. Kocyigit, F. Altuntaş, L. Kaynar, B. Eser. An Unusal Case of Acute Brucellosis Presented with Coombs-positive Autoimmune Hemolytic Anemia. Inter Med, 47(11),1043-1045, (2008).
  • 153. F. Altuntaş, İ. Aydogdu, S. Kabukcu, İ. Kocyigit, K. Cikim, İ. Sarı, M. Ali Erkut, B. Eser, A. Ozturk, E. Kaya, M. Cetin, A. Keskin, A. Unal. “Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study” Transfus Apher Sci, 36 (1), 57-67, (2007).
  • 154. F. Altuntaş, Kocyigit I, Ozturk A, Kaynar L, Sarı I, Oztekin M, Solmaz M, Eser B, Cetin M, Unal A. Comparison of the Fenwal Amicus and Fresenius Com.Tec Cell Separators for Autologous Peripheral Blood Progenitor Cell Collection. Transfus Apher Sci, 36 (2), 159-167, (2007).
  • 155. I. Sarı, F. Altuntaş, I. Kocyigit, Y. Sisman, B. Eser, A. Unal, T. Fen, A. Ferahbas, A. Ozturk, A. Unal, M. Cetin. The effect of budesonide mouthwash on oral chronic graft versus host disease. Am J Hematol, 82 (5), 349-356, (2007).
  • 156. F. Altuntaş, İ. Sarı, Ö. Canoz, B. Eser, O. Yıldız, M. Çetin, A.Ünal. “Kikuchi-Fujimoto disease: A rare but important cause of fever and lymphadenopathy in pregnant women”. Am J Hematol, 81(2), 118–120, (2006).
  • 157. B. Eser, F. Altuntaş, Ö. Er, O. Kontas, M. Cetin, A. Unal. “Acute Lymphoblastic Leukemia Associated with Brucellosis in Two Patients with Fever and Pancytopenia”. Yonsei Med J, 47(5), 741-744, (2006).
  • 158. B. Eser, I. Sarı, Ö. Canöz, F. Altuntaş, E. Cakmak, A. Ozturk, M. Ozkan, Ö. Er, M. Cetin, A. Unal. “Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma”. Am J Hematol, 81(5), 307–314, (2006).
  • 159. B. Eser, B. Kaplan, A. Unal, Ö. Canoz, F. Altuntaş, İ. Sarı, M. Cetin. “Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin’s Iymphomas in Central Anatolia, in Turkey”. Yonsei Medical Journal, 47(1), 22-33, (2006).
  • 160. R. Sarode, F. Altuntaş. “Blood bank issues associated with red cell exchanges in sickle cell disease”, J Clin Apher, 21(4), 271-273, (2006).
  • 161. Er O, Ozkan M, Altınbas M, Coskun HS, Eser B, F. Altuntaş, Cetin M, Unal A. Outpatient 5-Fluorouracil + Interferon alfa + Interleukin-2 Chemoimmunotherapy in Metastatic Renal Cell cancer Patients. Asia Pacific J Clin Oncol, 1, 145-150, (2005).
  • 162. M. Cetin, S. Buyukberber, M. Demir, İ. Sarı, K. Deniz, B. Eser, F. Altuntaş, C. Camci, A. Ozturk, B. Turgut, O. Vural, A. Unal. “Overexpression of Cyclooxygenase-2 in Multiple Myeloma: Associated with Reduced Survival”. Am J Hematol, 80, 169-173, (2005).
  • 163. F. Altuntaş, O. Yildiz, İ. Sarı, B. Eser, M. Cetin, A. Unal. “Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura”. Am J Haematol, 80, 204-205, (2005).
  • 164. C. Kucuk, E. Sozuer, E. Ok, F. Altuntaş, Z. Yilmaz. “Laparoscopic versus open splenectomy in the management of benign and malign hematologic diseases: a ten-year single-center experience”. J Laparoendosc Adv Surg Tech A, 15(2),135-139, (2005).
  • 165. HS. Coskun, Ö. Er, S. Soyuer, M. Altinbas, B. Eser, E. Karahacioglu, F. Altuntaş. “Solitary plasmacytoma: experiences from Central Anatolia”. Ir J Med Sci, 174(1), 33-36, (2005).
  • 166. B. Eser, M. Guven, A. Unal, R. Coskun, F. Altuntaş, M. Sungur, IS. Serin, İ. Sari, M. Cetin. “The Role of Plasma Exchange in HELLP Syndrome”. Clin Appl Thromb Hemost, 11 (2), 211-217, (2005).
  • 167. F. Altuntaş, O. Yıldız, B. Eser, İ. Sarı, M. Cetin, A. Unal. “Severe Thrombotic Microangiopathy Associated with Brucellosis: Successful Treatment with Plasmapheresis”. Clin Appl Thromb Hemost, 11(1),105-108, (2005).
  • 168. F. Altuntaş, O. Yildiz, B. Eser, K. Gündogan, B. Sumerkan, M. Çetin. “Catheter-Related Bacteremia Due to Kocuria Rosea in a Patient Undergoing Peripheral Blood Stem Cell Transplantation”. BMC Infectious Diseases, 4, 62, (2004).
  • 169. B. Barker, F. Altuntaş, G. Paranjape, R. Sarode. “Presurgical Plasma Exchange is Ineffective in Correcting Amyloid Associated Factor X Deficiency”. J Clin Apheresis, 19(4), 208-210, (2004).
  • 170. S. Yazar, O. Yaman, B. Eser, F. Altuntaş, F. Kurnaz, I. Sahin. “Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia”. J Med Microbiol, 53, 1183-1186, (2004).
  • 171. M. Ozkan, B. Eser, O. Er, F. Altuntaş, R. Coskun, R. Topsakal, E. Mavili, M. Kala, M. Altinbas. “Antiphospholipid syndrome associated with malignant mesothelioma presenting with superior vena cava thrombosis: a case report”. Clin Appl Thromb Hemost, 10(4), 393-396, (2004).
  • 172. B. Eser, F. Altuntaş, O. Er, O. Kontas, A. Ferahbas, M. Cetin, A. Unal. “A case of subcutaneous panniculitis-like T-cell lymphoma with haemophagocytosis developing secondary to chemotherapy”. J Eur Acad Dermatol Venereol, 18(6), 713-715, (2004).
  • 173. M. Guven, M. Sungur, B. Eser, I. Sarı, F. Altuntaş. “The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning”. J Toxicol Clin Toxicol, 42(5), 613-619, (2004).
  • 174. O. Er, HS. Coskun, M. Altinbas, M. Ozkan, B. Eser, M. Cetin, F. Altuntaş, A. Unal. “Meropenem +/- granulocyte colony stimulating factor in the treatment of febrile neutropenic patients with cancer: prospective randomized study”. J Chemother, 16(3), 288-92, (2004).
  • 175. S. Gullu, F. Altuntaş, I. Dincer, C. Erol, N. Kamel. “Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction”. Eur J Endocrinol, 150(5), 655-661, (2004).
  • 176. S. Yazar, F. Altuntaş, I. Şahin, M. Atambay. “Dysentery caused by Balantidium coli in a patient with non-Hodgkin’s Iymphoma from Turkey”. World J Gastroenterol, 10(3), 458-459, (2004).
  • 177. H. Akbulut, F. Altuntaş, KG. Akbulut, G. Ozturk, M. Cindoruk, E. Unal, F. Icli. “Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma”. Cytokine, 20(4), 184-190, (2002).
  • 178. K. Keven, SJ. Bengisun, F. Altuntaş, H. Akar, G. Nergizoglu, K. Sim, N. Duman, B. Erbay. “Cystic infection of the liver in a maintenance haemodialysis patient”. Nephrol Dial Transplant, 16(4), 859-860, (2001).
  • 179. Diğer: ...
  • 1. Bakırtaş M, Uncu Ulu B, Başcı S, Darçın T, Yıldız J, Seçilmiş S, Şahin D, İskender D, Baysal N, Merdin A, Batgi H, Yiğenoğlu T, Kızıl Çakır M, Dal S, Altuntaş F. Evaluation of seasonality in the diagnosis of diffuse large B cell lymphoma in Turkey. Journal of Health Sciences and Medicine. 2021; 4(2): 123-126.
  • 2. Bahar Uncu Ulu, Derya Şahin, Tuğçe Nur Yiğenoğlu, Tahir Darçın, Mehmet Bakırtaş, Semih Başcı, Jale Yıldız, Dicle İskender, Nuran Ahu Baysal, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntas. Consolidation With Autologous Stem Cell Transplantation In Patients With Primary Central Nervous System Lymphoma. Acta Oncologica Turcica 2021; 54.
  • 3. Duygu Mert, Alparslan Merdin, Nurten Kandemir, Merih Kızıl Çakar, Ece Dirim, Sabahat Çeken, Fevzi Altuntaş, Mustafa Ertek. Evaluation of risk factors and causative pathogens in bloodstream infections in cancer patients. Gulhane Med J 2021;63:42-51. DOI: 10.4274/gulhane.galenos.2020.1320.
  • 4. Jale Yıldız, Tuğçe Nur Yiğenoğlu, Alparslan Merdin, Bahar Uncu Ulu, Semih Başcı, Tahir Darçın, Samet Yaman, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntas. Is Autologous Stem Cell Transplantation a Risk For Divorce in Lymphoma Survivors? Acta Oncologica Tursica 2020; 53(4): 469-74. Doi: 10.5505/aot.2020.22448.
  • 5. Ayşegül Tetik, Bahar Uncu Ulu, Mehmet Bakırtaş, Tuğçe Nur Yiğenoğlu, Jale Yıldız, Semih Başcı, Hikmettullah Batgi, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntas. Erişkin Başlangıçlı Langerhans Hücreli Histiyositozis Tedavisinde Vinblastin Kemoterapisinin Yeri – Ankara Onkoloji Hastanesi Deneyimi. Acta Oncologica Tursica 2020; 53(4): 492-99. Doi: 10.5505/aot.2020.37097.
  • 6. Sabahat Çeken, Merih Kızıl Çakar, Gülşen İskender, Duygu Mert, Habip Gedik, Göknur Yapar Toros, Mehmet Sinan Dal, Fevzi Altuntas, Mustafa Ertek. The Importance of Antiviral Prophylaxis in Anti Hbc Positive Patients with Autologous Haematopoietic Stem Cell Transplantation.Acta Oncologica Tursica 2020; 53(4): 523-31. Doi: 10.5505/aot.2020.81894.
  • 7. Semih Başcı, Tuğçe Nur Yiğenoğlu, Derya Şahin, Özcan Saygılı, Mehmet Bakırtaş, Bahar Uncu Ulu, Tahir Darçın, Alparslan Merdin, Dicle İskender, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntas. The Relationship Between ABO and Rh Blood Groups with Acute Lymphoblastic Leukemia. Acta Oncologica Tursica 2020; 53(2): 357-61. Doi: 10.5505/aot.2020.97720.
  • 8. Mehmet Bakırtaş, Taha Bahsi, Tuğçe Nur Yiğenoğlu, Haktan Bagis Erdem, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş. Genetic Alterations In Turkish Patients With Multiple Myeloma: A Single Center Experience. Acta Oncologica Tursica 2020; 53(3): 458-62. Doi: 10.5505/aot.2020.02439.
  • 9. Derya Şahin, Tuğçe Nur Yiğenoğlu, Semih Başcı, Bahar Uncu Ulu, Tahir Darçın, Mehmet Bakırtaş, Jale Yıldız, Alparslan Merdin, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş. Stem Cell Transplantation and Medical Tourism at Ankara Oncology Training and Research Hospital. Acta Oncologica Tursica 2020; 53(1): 113-116. Doi: 10.5505/aot.2020.27167.
  • 10. Semih Başcı, Tuğçe Nur Yiğenoğlu, Mehmet Bakırtaş, Bahar Uncu Ulu, Derya Şahin, Tahir Darçın, Jale Yıldız, Dicle İskender, Nuran Ahu Baysal, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Adult aplastic anemia patients can maintain remission after allogeneic hematopoietic stem cell transplantation in a mixed chimeric state. J Surg Med. 2020;4(9):729-732. DOI: 10.28982/josam.721362.
  • 11. Fevzi Altuntaş Tuğçe Nur Yiğenoğlu, Semih Başcı, Mehmet Bakırtaş, Bahar Uncu Ulu, Derya Şahin, Tahir Darçın, Jale Yıldız, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal. The Value Of International Staging System In Predicting Survival of Multiple Myeloma Patients With Renal Failure. Dicle Medical Journal. 2020/6
  • 12. Tuğçe Nur Yiğenoğlu, Taha Bahsi, Dr. Haktan Erdem, Dr. Neslihan Duzkale, Bahar Uncu Ulu, Dicle İskender, Merih Kızıl Çakır, Sinan Dal, Fevzi Altuntaş. P210 breakpoint is associated with less minimal residual disease compared to p190 breakpoint in acute lymphoblastic leukemia patients with Philadelphia chromosome. Journal of Health Sciences and Medicine 2020;3(3): 307-311.
  • 13. Tuğçe Nur Yiğenoğlu, Semih Başcı, Derya Şahin, Mehmet Bakırtaş, Yüksek Lisans Ali Kılınc, Bahar Uncu Ulu, Hikmetullah Batgi, Dicle İskender, Nurgul Ozcan, Merih Kızıl Çakır, Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş. The effect of smoking on stem cell mobilization in allogeneic donors. Journal of Health Sciences and Medicine 2020;3(3): 291-294.
  • 14. Derya Şahin, Semih Başçı, Ayşe Temizel, Hikmetullah Batgi, Bahar Uncu Ulu, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakır, Sinan Dal, Fevzi Altuntaş. The relationship between ABO blood groups and acute myeloid leukemia. Journal of Health Sciences and Medicine 2020;3(3): 219-222. DOI: 10.32322/jhsm.684289.
  • 15. Mehmet Bakırtaş, Bahar Uncu Ulu, Semih Başcı, Tuğçe Nur Yiğenoğlu, Jale Yıldız, Alparslan Merdin, Derya Şahin, Tahir Darçın, Dicle İskender, Merih Kızıl Çakar, Mehmet Sınan Dal, Fevzi Altuntas. Allogeneic Stem Cell Transplantation in Relapsing Multipl Myeloma after Autologous Stem Cell Transplantation: Single Center Experience. Acta Oncologica Tursica 2020; 53(1):108-112. Doi: 10.5505/aot.2020.75769.
  • 16. Tugce Nur Yigenoglu, Semih Basci, Bahar Uncu Ulu, Mehmet Bakirtas, Derya Sahin, Tahir Darcin, Jale Yildiz, Alparslan Merdin, Nuran Ahu Baysal, Dicle Iskender, Merih Kizil Cakar, Mehmet Sinan Dal, Fevzi Altuntas. The Outcome of Autologous Stem Cell Transplantation in Adolescent and Young Adult Patients with Multiple Myeloma. EJMO 2020;4(1):79–83. DOI: 10.14744/ejmo.2020.52684.
  • 17. Tarçın T, Merdin A, Ozcan N, Bakırtas M, Dal MS, Iskender D, Kızıl M, Altuntas F. Paroxysmal Nocturnal Hemoglobinuria Presenting with Hemolysis and Abdominal Pain. Acta Oncologica Tursica 2019;4: 489. Doi: 10.5505/aot.2019.46034.
  • 18. Taha Bahsi, Tuğçe Nur Yiğenoğlu, Haktan Bağış Erdem, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş. Evaluation of Clinical Outcome and Mixed Chimerism Follow-up after Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies. Gazi Medical Journal 2019;12-21.
  • 19. Özcan Saygılı, Bahar Uncu Ulu, Mehmet Bakırtaş, Dicle İskender, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. An Elderly Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Case Developed After 3 years of Post-chemotherapy. Acta Oncologica Tursica 2019;4: 485. Doi: 10.5505/aot.2019.68736.
  • 20. Alparslan Merdin, Jale Yıldız , Mehmet Sinan Dal, Merih Kızıl Çakar, Ali Hakan Kaya, Emre Tekgündüz, Aykut Onursever, Fevzi Altuntaş. A Unicenter Study About The Frequency of Hypokalemia and The Frequency of High Creatinine Levels In Hematology Inpatient Unit. Acta Oncologica Tursica 2018; DOI: 10.5505/aot.2018.63497.
  • 21. Alparslan Merdin, Jale Yıldız , Mehmet Sinan Dal, Merih Kızıl Çakar, Ali Hakan Kaya, Emre Tekgündüz, Aykut Onursever, Fevzi Altuntaş. Development of Acute Myelogenous Leukemia in an Allogeneic Hematopoietic Stem Cell Transplantated Patient with Fanconi Anemia. Acta Oncologica Tursica 2017; 50 (3):266-268. Doi: 10.5505/aot.2017.83997.
  • 22. Kaya H, Fevzi Altuntaş. Hodgkin Lenfoma. Turkiye Klinikleri J Hematol-Special Topics 2017;10(2):135-41.
  • 23. Fusun Gediz ÖZDEMİRKIRAN, Hikmet BATGİ, Mehmet DOĞAN, Emre TEKGÜNDÜZ, Fevzi ALTUNTAŞ. Bronchoesophageal Fistula in a Patient Presenting with Primary Effusion Lymphoma. Medical Journal of Aegean Clinics 2016; Vol: 54 No: : 49-51.
  • 24. Sinem Namdaroğlu, Emre Tekgündüz, Sinem Bozdağ, Ali Hakan Kaya, Fevzi Altuntaş. Coexistence of Primary Myelodysplastic Syndrome and Multiple Myeloma. Acta Oncol Tur. 2016; 49(3): 216-219 | DOI: 10.5505/aot.2016.35220.
  • 25. Sinan Dal, Ömür Kayıkçı, Fevzi Altuntaş. Hematolojik Malignitelerde Tromboz. Turkiye Klinikleri J Hematol-Special Topics 2016;9(4):37-43.
  • 26. Gülşen İskender, Sabahat Çeken, Itır Şirinoğlu Demiriz, Mustafa Ertek, Fevzi Altuntaş. İmmünsüpresif tedavi alan aplastik anemili bir hastada salmonella bakteremisi. Pam Tıp Derg 2016; 9(1):79-82. doi: 10.5505/ptd.2016.60566.
  • 27. Erol Çakmak, İsmail Sarı, Özlem Canoz, Bülent Eser, Fevzi Altuntaş, Mustafa Çetin, Ali Ünal. Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. Erciyes Med J 2015; 37(3): 102-5 • DOI: 10.5152/etd.2015.150001.
  • 28. Ali Hakan Kaya, Gökçe Kübra Taşkın, Sinem Civriz Bozdağ, Emre Tekgündüz, Fevzi Altuntaş. Kanser tedavisi sonrası gelişen iki ikincil akut lenfoblastik lösemi olgusu. Turkiye Klinikleri J Case Rep 2015;23(2):182-85. doi: 10.5336/caserep.2013-37455.
  • 29. Itır ŞİRİNOĞLU DEMİRİZ, Sinem NAMDAROĞLU, Fevzi ALTUNTAŞ. Primer Merkezi Sinir Sistemi Lenfomaları. Turkiye Klinikleri J Med Oncol-Special Topics 2013;6(1):50-7.
  • 30. Ali Hakan KAYA, Ali İrfan Emre TEKGÜNDÜZ, Fevzi ALTUNTAŞ. Multipl Myelomda Tedaviye Cevabın Değerlendirilmesi. Turkiye Klinikleri J Hematol-Special Topics 2013; 6(4):30-4.
  • 31. Altuntaş F, Özen M. Klinik Olgu Çözümleri Hematoloji. Olgu 22. 68 yaşında erkek hasta baş ağrısı ve konfüzyonu var. Çeviri Editörü: Mustafa Çetin. Nobel Kitabevi, 2012. ISBN: 9786053971207.
  • 32. F. Altuntaş. Lenfomalarda kanıta dayalı bakışla transplantasyon. Turkiye Klinikleri J Hem Onc-Special Topics, 5(3), 59-65 (2012).
  • 33. Cem Şahin, Leylagül Kaynar, Fatih Kurnaz, Çiğdem Pala, Serdar Şıvgın, Bülent Eser, Fevzi Altuntaş, Mustafa Çetin, Ali Ünal. Factors That Affect Survival in Patients with Allogeneic Hematopoetic Stem Cell Transplantation. Erciyes Med J 2012; 34: 178-183. DOI: 10.5152/etd.2012.48.
  • 34. M. Bulut, F. Altuntaş. Kan Komponenti Transfüzyon İlkeleri. Turkiye Klinikleri J Hem Onc-Special Topics, 4(2), 91-9, (2011).
  • 35. İ. Sarı, F. Altuntaş. Kök Hücre Naklinde GVHH Dışı Erken Dönem Komplikasyonlar. Hematolog, 1 (1), 95-114, (2011).
  • 36. S. Kabukcu, F. Altuntaş. Akut myeloid lösemide hemopoietik kök hücre nakli: Kime? Ne zaman? Nasıl?. Turkiye Klinikleri J Hem Onc-Special Topics, 3(2),41-54, (2010).
  • 37. F. Altuntaş, O İlhan. Akut lenfoblastik lösemide kök hücre nakli: Kime? Ne zaman? Nasıl?. Turkiye Klinikleri J Hem Onc-Special Topics,3(2),112-24, (2010).
  • 38. M. Sipahioglu, F. Altuntas, A. Aybal, A. Ünal, L. Kaynar, O. Kontas, O. Oymak, A. Ünal, Cengiz Utas. Primary Brain T-cell Lymphoma Concomitant with CNS Tuberculosis in a Kidney Transplant Patient. Erciyes Medical Journal, 31(3), 256-260, (2009).
  • 39. I. Sarı, M. Kula, B. Eser, L. Kaynar, F. Altuntaş, I. Koçyiğit, E. Mavili, A. Tutuş, M. Çetin, A. Ünal. Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma. Erciyes Medical Journal, 30(1), 008-013, (2008).
  • 40. I. Sarı, L. Kaynar, I. Koçyiğit, F. Altuntas. The Use of High Dose Acyclovir in Patients with Hematological Malignancies Developing Herpes Virus Infections: Is it really safe? Turk J Hematol, 25(4), 205-206, (2008).
  • 41. H. Demiraslan, O. Yıldız, L. Kaynar, F. Altuntaş, B. Eser, B. Aygen. Febril Nötropenik Hastalardan İzole Edilen Mikroorganizmalar ve Antimikrobiyal Duyarlılıkları: 2005 Yılı Verileri. Erciyes Tıp Dergisi, 29(5), 376-380, (2007).
  • 42. L. Kaynar, F. Altuntas. Transfüzyon Öncesi Karşılaştırma Testleri. Turkiye Klinikleri J Int Med Sci, 3(36), 33-43, (2007).
  • 43. İ. Sarı, A. Aybal, B. Eser, A. Ünal, F. Altuntaş, A. Ünal, M. Cetin. Juguler santral venöz kateterizasyona bağlı Horner sendromu: Bir olgu sunumu. Erciyes Tıp Dergisi, 28 (4), 230–232, (2006).
  • 44. F. Altuntas, O. Yildiz, B. Eser, E. Alp, I. Sarı, M. Cetin, B. Sumerkan, A. Unal. Microbiologically documented infections following peripheral blood stem cell transplantation: Single center experience. Turkish J Hematol, 22 (3),133–145, (2005).
  • 45. F. Altuntaş, AR. Uysal, D. Çorapçıoğlu, Ç. Erol. Twice Weekly L-T4 For The Treatment Of Primary Hypothyroidism. Turkish J Endocrinology and metabolism, 8(1), 25–34, (2004).
  • 46. F. Altuntaş, L. Kaynar, B. Eser, I. Sarı, B. Kaplan, M. Özkan, M. Çetin, A. Ünal. Multipl myeloma tedavisinde üç farklı konvansiyonel kemoterapi protokolünün karşılaştırılması: Tek merkez deneyimi. Türk Onkoloji Dergisi, 19, 9–14, (2004).
  • 47. F. Altuntaş, B. Eser, Ö. Canöz, Ö. Er, M. Özkan, S. Şıvgın, M. Çetin, A. Ünal. Kronik Lenfositik Lösemi/Lenfoma’da Fludarabin Tabanlı Kemoterapi. THOD, 2 (14),1–6, (2004).
  • 48. F. Altuntaş, O. Yıldız, A. Ünal. Hematolojik Maligniteli Hastalarda İntravenöz Kateter İnfeksiyonları. Erciyes Tıp Dergisi, 26 (1), 25–32, (2004).
  • 49. F. Altuntaş, B. Eser, M. Sipahioğlu, Ö. Canöz, E. Ekici, M. Çetin, A. Ünal. Kanama diatezi ile seyreden bir antifosfolipid antikor sendromu olgusu. Erciyes Tıp Dergisi, 26(3), 141–144, (2004).
  • 50. F. Altuntaş, L. Kaynar, B. Eser, C. Küçük, MA. Yücel, M. Çetin, A. Ünal. İmmün Trombositopenik purpuralı olguların değerlendirilmesi: Bir merkezin sonuçları. Türkiye Tıp Dergisi, 4, 65–71, (2004).
  • 51. M. Altınbaş, M. Özkan, Ö. Er, HS. Coşkun, B. Kaplan, C. Küçük, F. Altuntaş, B. Eser. Gemcitabine and cisplatin in the treatment of patients with locally advanced and metastatic pancreatic carcinoma. Turkish Journal of Cancer, 33(4),181-186, (2003).
  • 52. A. Ünal, F. Altuntaş. Meme Dışı Solid tümörlerde yüksek doz tedavi ve otolog periferik kök hücre nakli. Türkiye klinikleri, Hematoloji Dergisi, 1(1), 99-103, (2003).
  • 53. M. Özkan, Ö. Er, B. Kaplan, HŞ. Coşkun, F. Altuntaş, B. Eser, M. Altınbaş. Rezeke edilmeyen akciğer adenokarsinomlarında klinik seyir. THOD, 4(13), 212-217, (2003).
  • 54. F. Altuntaş, B. Eser, B. Kaplan, Ö. Canöz, K. Gündoğan, M. Özkan, Ö. Er, HŞ. Coşkun, M. Çetin, E. Karahacıoğlu, A. Ünal. Hodgkin hastalığında ilk basamak tedavi sonuçları: tek merkez deneyimi. Türk Hematoloji Onkoloji Dergisi, 2(13), 79–86, (2003).
  • 55. F. Altuntas, M. Arat, O. İlhan. Radyoterapi Alan Anemik Kanserli Hastalarda Eritropoetin’in Klinik Kullanımı. Erciyes Tıp Dergisi, 25(1), 45-53, (2003).
  • 56. M. Özkan, Ö. Er, B. Kaplan, HŞ. Coşkun, O. Yıldız, F. Altuntaş, B. Eser, K. Uçar, F. Kurnaz, M. Altınbaş. Akciğer Malign Tümörlerinde Vena Kava Süperior Sendromu Gelişmesi Kötü Prognostik Bir Faktör mü?. Türk Onkoloji Dergisi, 18 (2), 60–63, (2003).
  • 57. ÖU. Gürkan, F. Altuntaş, Ö. Kumbasar, T. Acıcan, S. Saryal, D. Alper. Kritik hasta nöropatisi ile komplike olmuş ilginç bir ARDS olgusu. Tüberküloz ve Toraks, 49(3), 401–404, (2001).
  • 58. S. Özbaş, D. Çorapçıoğlu, F. Altuntaş, B. Yanık, SD. Sak, S. Koçak. Kist Hidatik Görünümü Veren Bir Tiroid Kisti: Vaka Sunumu. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 52(4), 247–250, (1999).
  • 59. A. Demirkazık, A. Arıcan, F. Altuntaş, D. Dinçol, H. Karaoğuz, F. Çay, H. Akbulut, F. İçli. Results of Mitomycin-C Plus Vinblastine Plus Cisplatin Combination Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer In Turkey. Acta Oncologica Turcica, 30 (1-4), 4-8, (1997).
  • 60. Diğer: ...
  • 1. Meral Beksac, Güldane Cengiz Seval, Semra Paydaş, Tülin Fıratlı Tuglular, Önder Arslan, Hakan Goker, Leylagul Kaynar, Fevzi Altuntaş, figen atalay, Havva Üsküdar Teke, Ali Zahit Bolaman, Mustafa Pehlivan, Mehmet Sonmez, Ahmet ŞMuzaffer Demir, Mehmet Yılmaz, Sibel Hacıoğlu Kabukçu, Murat Albayrak, Nurgul Özgür Yurttaş, Ayşe Salihoğlu, Merih Kızıl Çakar, Gunhan Gurman. Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable ≥Vgpr Responses Among Immunomodulatory / Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey. SP-076. Clin Lymph Myeloma Leukemia October 2019, Volume 19, Issue 10, Supplement 1, Pages e242–e243 DOI: https://doi.org/10.1016/j.clml.2019.09.402.
  • 2. Tulin Tuglular, Ridvan Ali, Mehmet Turgut, Guray Saydam, Selim Yavuz, Ali Unal, Muhlis Cem Ar, Orhan Ayyildiz, Fevzi Altuntas, Mufide Okay, Rafiye Ciftciler, Ozgur Meletli, Nur Soyer, Metban Mastanzade, Zeynep Guven, Teoman Soysal, Abdullah Karakus, Tugce Nur Yigenoglu, Aslihan Sezgin, Baris Ucar, Ece Gokcen, Yahya Buyukasik. PATTERNS OF HYDROXYUREA PRESCRIPTION AND USE IN ROUTINE CLINICAL MANAGEMENT OF POLYCYTHAEMIA VERA: A MULTICENTRE CHART REVIEW STUDY. 25th Congress of the European Hematology Association to be held in Frankfurt, Germany from June 11 - 14, 2020, EHA-2737.
  • 3. Demirkan, F., Ciftciler, R., Sevindik, O. G., Tekgündüz, E., Erkurt, M. A., Vural, F., Turgut B, Kaynar L, Payzın K, Doğu, MH, Karakus, V, Altuntas F, Buyukasık Y. Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data. Blood 2019; 134 (Supplement-1): 5073. https://doi.org/10.1182/blood-2019-126006.
  • 4. Derya Sahin, Tugce Yigenoglu, Tahir Darcın, Semih Bascı, Ozcan Saygılı, Bahar Ulu, Alparslan Merdin, Jale Yıldız, Mehmet Bakırtas, Aysegül Tetik, Dicle Iskender, Merih Cakar, Mehmet Dal, Fevzi Altuntas. The Relationship Between ABO and Rhesus Blood Groups and Acute Lymphoblastic Leukemia. ALL-0237. Clin Lymph Myeloma Leukemia October 2019, Volume 19, Issue 10, Supplement 1, Page S192. DOI: https://doi.org/10.1016/j.clml.2019.07.037.
  • 5. Tahir Darcın, Tugce Yigenoglu, Derya Sahin, Mehmet Bakırtas, Semih Bascı, Alparslan Merdin, Jale Yıldız, Bahar Ulu, Aysegül Tetik, Dicle Iskender, Merih Cakar, Mehmet Sinan Dal, Fevzi Altuntas. Inotuzumab Ozogamicin Salvage Monotherapy for the Treatment of Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia. ALL-0238. Clin Lymph Myeloma Leukemia October 2019, Volume 19, Issue 10, Supplement 1, Page S192-S193. DOI: https://doi.org/10.1016/j.clml.2019.07.038.
  • 6. Tahir Darcın, Tugce Yigenoglu, Derya Sahin, Mehmet Bakırtas, Semih Bascı, Alparslan Merdin, Jale Yıldız, Bahar Ulu, Aysegül Tetik, Dicle Iskender, Merih Cakar, Mehmet Sinan Dal, Fevzi Altuntas. Polatuzumab Vedotin in Combination with Bendamustine Plus Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Our Experience. ALL-0244. Clin Lymph Myeloma Leukemia October 2019, Volume 19, Issue 10, Supplement 1, Page S249-S250. DOI: https://doi.org/10.1016/j.clml.2019.07.155.
  • 7. Yigenoglu, T. N; Ulu, Uncu B; Bascı, S; Bakırtas, M; Darcın, T; Sahin, D; Iskender, D; Cakar, Kizil M; Dal, M. S; Altuntas, F. ONCE- VERSUS TWICE-DAILY FILGRASTIM FOR MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS FROM HEALTHY DONORS: SINGLE CENTER EXPERIENCE. HemaSphere: June 2019 - Volume 3 - Issue - p 1054. doi: 10.1097/01.HS9.0000567936.83974.3f.
  • 8. Ulu, Uncu B; Yiğenoğlu, T. N; Merdin, A; Bakırtaş, M; Başçı, S; Şahin, D; Darçın, T; İskender, D; Çakar, Kızıl M; Dal, M. S; Altuntaş, F. BRENTUXIMAB VEDOTIN PLUS BENDAMUSTINE IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: A SINGLE CENTER EXPERIENCE. HemaSphere: June 2019 - Volume 3 - Issue - p 907. doi: 10.1097/01.HS9.0000566516.75354.f8.
  • 9. Sahin, D; Yigenoglu, T. N; Saygılı, O; Bascı, S; Ulu, Uncu B; Darcın, T; Bakırtas, M; Iskender, D; Cakar, Kızıl M; Dal, M. S; Altuntas, F. ADULT ACUTE LEUKEMIA AND SEASONALITY: A SINGLE CENTER EXPERIENCE. HemaSphere: June 2019 - Volume 3 - Issue - p 776. doi: 10.1097/01.HS9.0000565244.53999.b3.
  • 10. Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Fevzi Altuntaş. A CASE OF RECTUS SHEATH HEMATOMA FOLLOWING ADMINISTRATION OF ENOXAPARIN IN A CMML PATIENT. 1st International Encounter in Thrombosis and Hematology. IETH 2018;2-P
  • 11. Soyer N. , Gunduz M., TEKGUNDUZ E., Sahin H. H. , Yildizhan E., OKAY M., Altuntas F, et al. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of Turkish Hematology Research and Education Group (ThREG). 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52.
  • 12. Kaya, A. H., Tekgunduz, E., Bekdemir, F., Batgi, H., Yigenoglu, T., Ulu, B. U., Bilge Ugur, Dicle Iskender, Merih Kizil Cakar, Mehmet Sinan Dal & Akpinar, S, Demirkan F, Altuntas F. (2016). Is It Time for Early Cessation of Empirical Antibiotherapy in Patients Presenting with Febrile Neutropenia? Preliminary Results of a Risk-Adapted Approach in a Hematology Clinic. Blood, 128(22), 2503-2503.
  • 13. Emre Tekgunduz, Mehmet Yilmaz, Mehmet Ali Erkurt, Ilhami Kiki, Ali Hakan Kaya, Leylagul Kaynar, Inci Alacacioglu, Guven Cetin, Ibrahim Ozarslan, Irfan Kuku, Gulden Sincan, Ozan Salim, Sinem Namdaroglu, Abdullah Karakuş, Volkan Karakuş, GulsumEmel Pamuk, Fevzi Altuntas, HakanIsmail Sari, Gulsum Ozet, Ismet Aydogdu, Vahap Okan, Emin Kaya, Rahsan Yildirim, Esra Yildizhan, Gokhan Ozgur, OsmanIlhami Ozcebe, Bahriye Payzin, Seval Akpinar and Fatih Demirkan (2016). A Multicenter Experience of Thrombotic Microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 Study. Blood, 128(22), 4933-4933.
  • 14. Pamuk, G. E., Maden, M., Pamuk, O. N., Sincan, G., Yildizhan, E., Turak, E. E., ... & Ilhan, G, Altuntas F. (2016, May). Effect of pregnancy on the course of immune thrombocytopenia: a retrospective multicenter study. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS (Vol. 14, pp. 162-162).
  • 15. Pamuk, G. E., Maden, M., Sari, H., Erkurt, M. A., Keskinkilic, M., Cagliyan, A. G., ... & Kuku, I, Altuntas F. (2016, May). The outcome of eltrombopag therapy in immune thrombocytopenia: a multicenter study from Turkey. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS (Vol. 14, pp. 101-101)..
  • 16. Tekgunduz, E., Kaya, A. H., Bekdemir, F., Batgi, H., Ulu, B. U., Yigenoglu, T. N., ... & Altuntas, F. (2016, March). Preliminary results of patients who received haploidentical-related donor HCT: a single center, retrospective report. In BONE MARROW TRANSPLANTATION (Vol. 51, pp. S155-S155).
  • 17. Kocubaba, S., Adibelli, G., Citlak, K., Kilinc, A., Kayikci, O., Tekgunduz, A. I. E., & Altuntas, F. (2016, March). THE FIRST HEMATOPOIETIC CELL TRANSPLANTATION (HCT) ACTIVITY IN UZBEKISTAN AND IMPORTANT ROLE OF TRAINING IN HCT NURSING. In BONE MARROW TRANSPLANTATION (Vol. 51, pp. S526-S526).
  • 18. Tekgündüz, E., Kaya, A., Bozdağ, S., Doğu, M., Dal, M., Bekdemir, F., ... & Altuntas, F. (2016). Clofarabine and Cytarabine Combination in Patients with Fludarabine/Cytarabine Refractory Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia, 16, S24-S25.
  • 19. Kaya, A., Tekgündüz, E., Akpınar, S., Kayıkçı, Ö., Bekdemir, F., Ugur, B., Batgi H, Yigenoglu T, Ulu B, Dal M, İskender, D, Kızıl M, Altuntas F. (2016). Routine CMV Surveillance in Autologous Hematopoietic Cell Transplantation Setting: is It Time for Rethink?. Clinical Lymphoma, Myeloma and Leukemia, 16, S120.
  • 20. Mehmet Hilmi Dogu, Muzaffer Keklik, Hatice Terzi, Serdal Korkmaz, Mehmet Ali Erkurt, Gulsum Akgun Caglıyan, Leylagül Kaynar, Serdar Sivgin, Ismail Sarı, Ali Keskin, Mehmet Sencan, Fevzi Altuntas, Osman Ilhan. Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes. Clinical Lymphoma Myeloma and Leukemia June 2015 Volume 15, Supplement, Page S218.
  • 21. A. Kaya, E. Tekgunduz, D. Iskender, H. Batgi, F. Bekdemir, F. Altuntas. Retrospective evaluation of azacitidine monotherapy in patients with myelodysplastic syndrome: a single center experience. 13th International Symposium on Myelodysplastic Syndromes. 29 April 2015 - 02 May 2015. Leukemia Research April 2015 (39); Supplement 1: S133–S134.
  • 22. Ali Irfan Emre Tekgündüz, Omür Kayıkcı, Sinem Civriz Bozdag, Ali Hakan Kaya, Serife Kocubaba, Sinem Namdaroglu, Bilge Ugur, Fevzi Altuntas. Preliminary results of acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic cell transplantation: A single center experience. 41th European Group for Bone and Marrow Transplantation, 22-25, March 2015, Istanbul, Turkey. Bone Marrow Transplantation, 50 (Supplement 1), AB060, (2015).
  • 23. Ali Irfan Emre Tekgündüz, Ali Hakan Hakan Kaya, Sinem Civriz Bozdag, Serife Kocubaba, Omür Kayıkcı, Sinem Namdaroglu, Bilge Ugur, Fevzi Altuntas. Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?a retrospective analysis. 41th European Group for Bone and Marrow Transplantation, 22-25, March 2015, Istanbul, Turkey. Bone Marrow Transplantation, 50 (Supplement 1), P089, (2015).
  • 24. Ali Irfan Emre Tekgunduz, Ali Hakan Kaya, Hakan Göker, Evren Ozdemir, Dicle Iskender, Serife Kocubaba, Omur Kayıkcı, Fevzi Altuntas. Biosimilar filgrastim (Leucostim®) seems to have similar efficacy in hematopoietic progenitor cell mobilization compared to original filgrastim (Neupogen®) and lenograstim (Granocyte®): a retrospective, multicenter analysis. 41th European Group for Bone and Marrow Transplantation, 22-25, March 2015, Istanbul, Turkey. Bone Marrow Transplantation, 50 (Supplement 1), P429, (2015).
  • 25. Meral Beksac, Fatma Savran Oguz, Pervin Topcuoglu, Gulsun Karasu, Mutlu Arat, Serap Aksoylar, Savas Kansoy, Sevgi Kalayoglu Besisik, Alphan Kupesiz, Volkan Hazar, Fevzi Altuntas, Ali Unal, Zafer Gulbas, Fatma Deniz Sargin, Osman Ilhan, Gunhan Gurman, Akif Yesilipek. HLA-A allele mismatch (7/8 or 9/10) is the second best option after 8/8 or 10/10 matched unrelated donors: An analysis on results from Turkish centers. 41th European Group for Bone and Marrow Transplantation, 22-25, March 2015, Istanbul, Turkey. Bone Marrow Transplantation, 50 (Supplement 1), P480, (2015).
  • 26. Anil Tombak, Naci Tiftik, Mehmet Hilmi Dogu, Ismail Sari, Meltem Olga Akay, Mustafa Karagulle, Emin Kaya, Serdal Korkmaz, Mehmet Sencan, Gulsah Akyol, Leylagul Kaynar, Melda Comert, Guray Saydam, Sinan Mehmet Dal, Orhan M. Ayyildiz, Rahsan Yildirim, Ilhami Kiki, Erdal Kara, Ramazan Esen, Mehmet Ali Sungur, Mehmet Ali Erkurt, Fevzi Altuntas, Ali Unal, Osman Ilhan. The Clinical Characteristics and Therapeutic Outcomes of Elderly Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicenter Study. Blood December 6, 2014;124 (21):5644-5644. DOI: http://dx.doi.org/
  • 27. Hakan Goker, Eylem Eliacik, Fevzi Altuntas, Emre Tekgunduz, Evren Ozdemir, Ayse Isik, Omur Kayikci, Ali Hakan Kaya, Salih Aksu, Ibrahim C. Haznedaroglu, Nilgun Sayinalp, Haluk Demiroglu, Osman Ilhami Ozcebe,Yahya Buyukasik. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration. Blood December 6, 2014;124 (21): 5830 – 5830. DOI: http://dx.doi.org/
  • 28. Hakan Göker, Emre Tekgündüz, İsmail Sarı, Çiğdem Pala, Mehmet Hilmi Doğu, Erman Öztürk, Burhan Turgut, Serdal Korkmaz, Itır Şirinoğlu Demiriz, Yahya Büyükaşık, Sibel Hacıoğlu, Leylagül Kaynar, Sinem Civriz Bozdağ, Fevzi Altuntaş. Philadelphia-positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience. ASCO abstract. J Clin Oncol 2013, Chicago, USA.
  • 29. Omur Kayıkcı, Emre Tekgunduz, Sinem Civriz Bozdağ, itir demiriz, aysegül tetik, murat cinarsoy, sinem namdaroglu, bilge ugur, Fevzi Altuntas. Modified vigepp protocole as a new salvage regimen for relapsed refractory lymphoma patients. 18th Congress of European Hematology Association (EHA). "Haematologica 2013", pp 645 (abstract 4618), Stockholm, İsveç, Haziran 2013.
  • 30. Bilge ugur, Emre Tekgunduz, Sinem Civriz Bozdağ, aysegül tetik, itir demiriz, murat cinarsoy, Omur Kayıkcı, sinem namdaroglu, Fevzi Altuntas. The role of consolidative radiotherapy in diffuse large b cell lymphoma patients with bulky disease. 18th Congress of European Hematology Association (EHA). "Haematologica 2013", pp 641-642 (abstract 5582), Stockholm, İsveç, Haziran 2013.
  • 31. I. Sari, S. Korkmaz, M. Sencan, I. Kiki, E. N. Tiftik, H. Kaya, C. Demir, A. Unal, F. Altuntas, O. Ilhan. The clınıcal characterıstıcs and therapeutıc outcomes of elderly patıents wıth chronıc myeloıd leukemıa: a retrospectıve multıcenter study. SIOG13ABS-1196. 13th Conference of the International Society of Geriatric Oncology - SIOG 2013, Copenhagen, Denmark, 24 to 26 October 2013.
  • 32. Tetik A, Bozdağ SC, Tekgundüz E, Demiriz I, Kayıkçı Ö, Cınarsoy M, Namdaroğlu S, Ugur B, Altuntas F. Mesenchymal stem cell transplantation for steroid refractory GVHD: single center experience. 39th European Group for Bone and Marrow Transplantation/29th Meeting of the EBMT Nurses Group/12th Meeting of the EBMT Management Group, APR 07-10, 2013 London, England. Bone Marrow Transplantation, PP 180, (2013).
  • 33. F. Altuntaş, SC. Bozdağ, I. Demiriz, A. Tetik, O. Kayıkçı, M. Çınarsoy, S. Namdaroğlu, B. Uğur, E. Tekgunduz. BEAM or ICE? 2013 BMT Tandem Meeetings, February, 13-17 2013, Salt Lake City, UT, USA, P128. Biology of Blood and Marrow Transplantation, 19 (2), suppl 2, S178-179, (2013).
  • 34. Ismail Sari, Emin Kaya,Ilhami Kiki, Mehmet Sencan, Cengiz Demir, Naci Tiftik, Fevzi Altuntas, Osman Ilhan. Clinicopathologic features and treatment results of non-Hodgkin's lymphomas in elderly patients: A multicenter retrospective analysis from Turkey. Journal of Geriatric Oncology. Volume 3, Supplement 1 , Pages S63-S64, October 2012
  • 35. SC. Bozdağ, S. Kocubaba, Z. Genc, G. Durgun, M. Cinarsoy, A. Tetik, O. Kayikc, F. Altuntaş. Predicting the successful peripheral blood stem cell (PBSC) harvesting. 14th International Congress of the World Apheresis Association, September 13–15 2012, Istanbul, Turkey, p3 (O-05). Transfusion and Apheresis Science, S1–S20, (2012).
  • 36. S. Korkmaz, M. Keklik, S. Sivgin, R. Yildirim, A. Tombak, ME. Kaya, DY. Acik, R. Esen, S. Kabukcu, M. Sencan, I. Kiki, EN. Tiftik, I. Kuku, V. Okan, M. Yilmaz, C. Demir, I. Sari, F. Altuntaş, A. Unal, O. Ilhan. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study. 14th International Congress of the World Apheresis Association, September 13–15 2012, Istanbul, Turkey, p5 (O-09). Transfusion and Apheresis Science, S1–S20, (2012).
  • 37. IS. Demiriz, AIE. Tekgunduz, G. Durgun, A. Tetik, Z. Genc, SC Bozdag, S. Kocubaba, A. Sarica, A. Kilinc, F. Altuntaş. Bacterial contamination of hematopoietic stem cell products during collection and cryopreservation. 14th International Congress of the World Apheresis Association, September 13–15 2012, Istanbul, Turkey, p14 (O-25). Transfusion and Apheresis Science, S1–S20, (2012).
  • 38. SC. Bozdag, IS. Demiriz, AIE. Tekgunduz, A. Yurtcu, O. Kayikci, A. Tetik, S. Namdaroglu, B. Ugur, G. Durgun, F. Altuntaş. Systemic chemotherapy and G-CSF combination method for the hematopoietic stem cell mobilization. 14th International Congress of the World Apheresis Association, September 13–15 2012, Istanbul, Turkey, p15 (O-28). Transfusion and Apheresis Science, S1–S20, (2012).
  • 39. IS. Demiriz, AIE. Tekgunduz, SC. Bozdag, G. Durgun, Z. Genc, S. Kocubaba, O. Kayikci, S. Namdaroglu, B. Ugur, F. Altuntaş. Pretransplant specific comorbidity index as an outcome predictor for hematopoietic stem cell transplantation patients: single center experience. 14th International Congress of the World Apheresis Association, September 13–15 2012, Istanbul, Turkey, p21 (P-01). Transfusion and Apheresis Science, S1–S20, (2012).
  • 40. S. Ozturkmen, F. Altuntaş, L. Olcay. Granulocyte transfusion therapy in paediatric patients with severe neutropenic infection. 14th International Congress of the World Apheresis Association, September 13–15 2012, Istanbul, Turkey, p38 (p-36). Transfusion and Apheresis Science, S1–S20, (2012).
  • 41. AIE. Tekgunduz, IS. Demiriz, SC. Bozdag, A. Ozkaymak, I. Ucar, F. Ertem, O. Kayikci, A. Tetik, M. Cinarsoy, F. Altuntaş. Is it possible to predict relapse after allogeneic stem cell transplantation via bone marrow chimerism analysis? 14th International Congress of the World Apheresis Association, September 13–15 2012, Istanbul, Turkey, p42 (P-44). Transfusion and Apheresis Science, S1–S20, (2012).
  • 42. IS. Demiriz, S. Kocubaba, AIE. Tekgunduz, S. Civriz, A. Tetik, G. Durgun, Z. Genc, M. Cinarsoy, O. Kayikci, F. Altuntaş. Common adverse reactions during hematopoietic stem cell infusion. 14th International Congress of the World Apheresis Association, September 13–15 2012, Istanbul, Turkey, p42 (P-45). Transfusion and Apheresis Science, S1–S20, (2012).
  • 43. L. Kaynar, C. Sahin, F. Kurnaz, S. Sivgin, B. Eser, F. Altuntaş, I. Sari, E. Uzer, C. Pala, A. Unal, M. Cetin. Results of allogeneic haematopoietic stem cell transplant from Erciyes Capodoccia Transplantation Center: 11-year experience in centrall Anatolia. 37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group, APR 03-06, 2011, Paris, France. Bone Marrow Transplantation, 46 (Supplement 1), S188-S188, (2011).
  • 44. F. Kurnaz, L. Kaynar, B. Eser, M. Sekercan, F. Altuntaş, I. Sari, S. Sivgin, C. Pala, A. Unal, M. Cetin. Factors affecting engraftment time in patients undergoing allogeneic peripheral blood stem cell transplantation. 37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group, APR 03-06, 2011 Paris, France. Bone Marrow Transplantation, 46 (Supplement 1), S188-S188, (2011).
  • 45. C. Kis, M. Pehlivan, S. Pehlivan, B. Eser, T. Sever, M. Yilmaz, L. Kaynar, F. Altuntaş, S. Balci, M. Cetin. The importance of T315I, T317L, E255K and Y253H bcr-abl gene mutations in the patients of chronic myeloid leukemia who treated by imatinib. 15th Annual Meeting of the European-Hematology-Association, (Abstract: 1352), JUN 10-13, 2010, Barcelona, Spain. Haematologica, 95 (Supplement 2), 546-546, (2010).
  • 46. H.Arslan, Ü.Uyeturk, E. Yucel, M.Albayrak, F. Altuntaş. Reviewing of mantle cell lymphoma, Case of a young woman with mantle cell lymphoma. 1.st Congress of the Mediterranean Multidisciplinary Oncology Forum, 10-13 September 2009, Athens, Greece. Abstract book, 160, p41, (2009).
  • 47. F. Altuntaş, I. Kocyigit, F. Kurnaz, L. Kaynar, U. Korkmaz, M. Oztekin, M. Solmaz, B. Eser, M. Cetin, A. Unal. Complications of therapeutic plasma exchange: a single center experience. Interdisciplinary European Society for Haemapheresis and Haemotherapy (ESFH) Meeting, 16-19 September 2008 Duseldorf, Germany, p7.02. Transfus Med Hemother, 35 (suppl 1), 1-96, (2008).
  • 48. F. Altuntaş, I. Kocyigit, F. Kurnaz, F. Dogruel, M. Oztekin, M. Solmaz, B. Eser, K. Unlühızarcı, M. Cetin, A. Unal, F. Keleştimur. Therapeutic plasma exchange in patients with severe hyperthroidism: single center experience. Interdisciplinary European Society for Haemapheresis and Haemotherapy (ESFH) Meeting, 16-19 September 2008, Duseldorf, Germany,p7.03. Transfus Med Hemother, 35 (suppl 1), 1-96, (2008).
  • 49. I. Sarı, A. Cetin, L. Kaynar, R. Saraymen, SK. Hacioglu, A. Ozturk, I. Kocyigit, F. Altuntaş, B. Eser. Disturbance of the Pro-oxidative/Antioxidative Balance in Allogeneic Peripheral Blood Stem Cell Transplantation. 15th Annual Meeting of the European-Hematology-Association, (Abstract: 1405), JUN 12-15, 2008, Copenhagen, Denmark. Haematologica, 93, 535-535 (2008).
  • 50. A. Sahin, A. Unal, F. Kurnaz, L. Kaynar, M. Oztekin, M. Solmaz, F. Altuntaş, B. Eser, M. Cetin. The effects of plasma exchange on coagulatin parameters, and platelet functions in patients with multiple myeloma. Turkish Society of Hematology, 1st International Lymphoma - Leukemia - Myeloma (LLM) Congress (abstract 70), May 24-27 2007, Fethiye, Turkey. Turkish J Hematol, Proceedings and Abstract Book, 129, (2007).
  • 51. L. Kaynar, F. Altuntaş, SK. Hacioglu, I. Kocyigit, L. Akyol, M. Karakukcu, B. Eser, T. Patıroglu, A. Unal, M. Cetin. Rhabdomyolysis in a Allogeneic Peripheral Blood Stem Cell Donor. 33rd EBMT Annual Meeting, 25-28 March 2007, Lyon, France. Bone marrow Transplantation, 39 (suppl 1), S142-S142, (2007).
  • 52. F. Altuntaş, I. Kocyigit, L. Kaynar, I. Sarı, S. Kabukcu, M. Sekercan, O. Yıldız, O. Canöz, B. Eser, M. Sencan, M. Gülec, A. Unal, M. Cetin. Autologous peripheral blood stem cell transplatation in patients with relapsed non-Hodgkin lymphoma: cappadocia BMT centre experience. 33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, MAR 25-28, 2007, Lyon, France. Bone marrow transplantation, 39 (Supplement: 1), S318-S318, (2007).
  • 53. I. Sarı, F. Altuntaş, I. Kocyigit, Y. Sisman, B. Eser, A. Unal, T. Fen, A. Ferahbas, A. Oztürk, A. Unal, M. Cetin. Budesonide mouthwsah therapy: a safe and effective protocol for oral chronic graft-versus-host disease. 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group, MAR 19-22, 2006, Hamburg, Germany, (p421). Bone marrow Transplantation, 37 (suppl 1), S76-S76, (2006).
  • 54. M. Cetin, I. Sarı, F. Altuntaş, O. Yildiz, N. Koc, HM. Buldu, I. Kocyigit, B. Eser, A. Unal. Invazive fungal infection in allogeneic haematopoietic stem cell transplantation: the six-years experince of a Cappodoccia transplant center, Turkey. 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group, MAR 19-22, 2006, Hamburg, Germany, (p727). Bone marrow Transplantation, 37 (suppl 1), S186-S187, (2006).
  • 55. Unal A, Sari I, F. Altuntaş, Kocyigit I, Eser B, Cetin M. Allogeneic haematopoietic stem cell transplantation conditioned with intravenous busulfan and cyclophosphamide (IV BuCy2) in patients with haematologic malignancies: the experience of a Cappacloccia transplant centre, Turkey. 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group, MAR 19-22, 2006, Hamburg, Germany, (p727). Bone marrow Transplantation, 37 (suppl 1), S120-S120, (2006).
  • 56. F. Altuntaş, K. Matevosyan, J. Burner, C. Rutherford, R. Sarode. Lack of Correlation between OD Value of ELISA and Clinical Thrombosis in Patients with Heparin Induced Thrombocytopenia (HIT). XX Congress of the international society on thrombosis and haemostasis. Journal of thrombosis and Haemostasis, 3(suppl 8), (2005).
  • 57. F. Altuntaş, K. Matevosyan, J. Burner, R. Sarode. Analysis of Transfusion Medicine Physicians’ Calls. XXXth World Congress of the International Society of Hematology, 28 September- 3 October 2005, İstanbul, Turkey. Turkish J Hematol, 22 (suppl), p310, (2005).
  • 58. I. Sarı, F. Altuntaş, A. Unal, B. Eser, M. Borlu, A. Ferahbas, M. Cetin, A. Unal. Dermatomyositis after allogeneic stem cell transplantation as sole manifestation of acute graft versus host disease. XXXth World Congress of the International Society of Hematology, 28 September- 3 October 2005, İstanbul, Turkey. Turkish J Hematol, 22 (suppl), p797, (2005).
  • 59. I. Sarı, M. Cetin, F. Altuntaş B. Eser, T. Fen, A. Unal, A. Unal. A randomized, controlled study of EMA versus EMA-CyA in patients with relapsed or refractory acute myeloid leukemia. XXXth World Congress of the International Society of Hematology, 28 September- 3 October 2005, İstanbul, Turkey. Turkish J Hematol, 22 (suppl), p172, (2005).
  • 60. O. Yıldız, F. Altuntaş, I. Sarı, O. Coban, B. Eser, A. Unal, A. Unal, M. Cetin. Microbiological findings of early infection in allogeneic or otolog stem cell transplantation. 31st Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/21st Meeting of the EBMT-Nures-Group/4th Meeting of the EMBT-Data-Management-Group, MAR 20-23, 2005, Prague, Czech Republic. Bone Marrow Transplantation, 35 (suppl 2), R1147, (2005).
  • 61. M. Cetin, I. Sarı, O. Coban, B. Eser, F. Altuntaş, A. Unal. Comparison of different conditioning regimens used in relapse agressive non-Hodgkin lymphoma: ICE- CNV-BEAM. 31st Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/21st Meeting of the EBMT-Nures-Group/4th Meeting of the EMBT-Data-Management-Group, MAR 20-23, 2005, Prague, Czech Republic. Bone Marrow Transplantation, 35 (suppl 2), R1249, (2005).
  • 62. İ. Sarı, B. Eser, M. Kula, F. Altuntaş, E. Mavili, M. Özkan, M. Çetin, A. Tutuş, A. Ünal. GA-67 Uptake, A Predictor of Active Minimaly Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma. 9th Congress of the European Hematology-Association, (Abstract: 334), JUN 10-13, 2004, Geneva, Switzerland. The Hematology Journal, 5 (suppl. 2), 334, (2004).
  • 63. M. Çetin, F. Altuntaş, İ. Sarı, B. Eser, Ö. Er, Ö. Canöz, B. Kaplan, M. Özkan, E. Albayrak, S. Bahar, Y. Özkul, T. Patıroğlu, A. Ünal. Non-myeloablative stem cell transplantation for the treatment of haematologic malignancies and metastatic solid tumours: a single centre experience. 29th Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/19th Meeting of the EBMT-Nures-Group/2nd Meeting of the EMBT-Data-Management-Group, MAR 23-26, 2003, İstanbul, Turkey. Blood Marrow Transplantation, 31 (suppl 1) p158, (2003).
  • 64. S. Yazar, B. Eser, F. Altuntaş, F. Demirtaş, O. Yaman, S. Yalçın, M. Yay, M. Çetin, İ. Şahin, A. Ünal. Prevalence of anti-toxoplasma gondii antibodies in Turkish blood donors. VIII. European Congress of the International Society of Blood Transfusion, 5-9 July 2003 Istanbul, Türkiye. Abstract Book, p033, (2003).
  • 65. B. Eser, F. Altuntaş, B. Kaplan, Ö. Canöz, M. Özkan, Ö. Er, HŞ. Coşkun, K. Gundogan, M. Çetin, A. Ünal. Results of first line treatment in Hodgkin’s disease, single center experience. 8th Annual Congress of the European Hematology Association, 12-15 June 2003, Lyon, France. The Hematology Journal, 4 (supll 4), p0355, (2003).
  • 66. F. Altuntaş, B. Eser, Ö. Canöz, Ö. Er, M. Özkan, B. Kaplan, Ali Sahin, M. Cetin, A. Ünal. Fludarabine and fludarabine based combination chemotherapy in chronic lymphocytic leukemia/lymphoma. 8th Annual Congress of the European Hematology Association, 12-15 June 2003, Lyon, France. The Hematology Journal, 4 (supll 4), p0623, (2003).
  • 67. B. Eser, A. Ünal, R. Coşkun, M. Güven, F. Altuntaş, M. Sungur, İS. Serin, M. Çetin. Decreased mortality rate with plasma exchange in patients with Class 1 HELLP syndrome. 14th Congress of The Interdisciplinary European Society for Haemapheresis and Haemotherapy, 10-13 September 2003, Prague, Czech Republic. Abstract Book, oral P40, (2003).
  • 68. Ö. Er, H. Ş. Coşkun, M. Altınbaş, M. Özkan, B. Eser, M. Çetin, F. Altuntaş, A. Ünal. Meropenem +/- granulocyte colony stimulating factor in treatment of febrile neutropenic patients in cancer, Prospective randomized study. 27th ESMO Congress 18-22 October 2002, Nice, France. Annals of Oncology, 13 (suppl 5), P648, (2002).
  • 69. H. Akbulut, F. Altuntaş, G. Oztürk, GK. Akbulut, M. Cindoruk, U. Ekrem, F. İçli. A New Prognostic Angiogenic Index for the Patients with Colorectal Cancer. 37th Annual Meeting ASCO, May 12-15 2001, San Francisco, CA. Proceedings American Society of Clinical Oncology, 20 (part 2 of 2), 3109a, (2001).
  • 70. A. Arıcan, D. Dinçol, H. Akbulut, S. Sak, F. Altuntaş, G. Dursun, S. Yavuzer. Correlation between Serum p53 antibody and Tissue Mutant p53 in Lung and Larynx Cancers. 37th Annual Meeting ASCO, May 12-15 2001, San Francisco, CA. Proceedings American Society of Clinical Oncology, 20 (part 2 of 2), 2802a, (2001).
  • 71. D. Dincol, H. Akbulut, A. Arıcan, F. Altuntaş. Evalution of Serum p 53 Antibody in Smokers and Nonsmokers. 37th Annual Meeting ASCO, May 12-15 2001, San Francisco, CA. Proceedings American Society of Clinical Oncology, 20 (part 2 of 2), 2807a, (2001).
  • 72. M. Arat, Ö. Arslan, F. Altuntaş, E. Ayyıldız, A. Çiftçi, T. Demirer, O. İlhan. Stem Cell Mobilization with cyclophosphamide (Cy) based regimen in multiple myeloma: Ibn-i Sina Experience. XIII Congres of the Eurpean Society For Haemapheresis, September 16-19 2001, Trento, Italy. Abstract Book, p171a, (2001).
  • 73. M. Arat, F. Altuntaş, E. Akçağlayan, H. Çelebi, S. Bengisu, Ö. Başaran, E. Ünal, M. Özcan, Ö. Arslan, H. Akan. Hickman Catheter For Long-Term Venous Access In BMT Patients: Single Center Experience Of One Hundred Catheters. 26th Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/16th Meeting of the EBMT-Nures-Group, MAR 5-8, 2000, Innsbruck, Austria. Bone Marrow Transplantation, 25 (suppl 1), P907, (2000).
  • 74. Diğer: ...